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Kyle A. McGregor 
NEW APPROACHES TO RESEARCH WITH VULNERABLE POPULATIONS - 
INTERDISCIPLINARY APPLICATION OF A FRAMEWORK FOR 
VULNERABILITY AND ADOLESCENT CAPACITY TO CONSENT 
 Children’s and adolescents’ capacity to provide valid informed consent is one of 
the key ethical concerns in pediatric research, and the focus of this project. The original 
contribution to knowledge is the advancement of both conceptual and empirical 
bioethical approaches to research with vulnerable populations. First, a review of 
adolescent vulnerability is presented to highlight the complex interplay between capacity 
and other forms of vulnerability. This review is offered as an interdisciplinary analysis to 
better understand why the study of vulnerable populations is critical to the ethical 
advancement of clinical research. Results from this analysis suggest the need for 
enhanced screening techniques as well as the utilization of specialized staff to identify 
and reduce the impact of different forms of vulnerability. 
 The primary tasks of the empirical portion of the dissertation were to: (1) Adapt a 
validated adult competency assessment tool for clinical research, the MacArthur 
Competency Assessment Tool for Clinical Research, to assess the capacity of children 
and adolescents to consent to clinical research; (2) Identify predictors that impact 
children and adolescents’ capacity to provide consent to clinical research; and (3) assess 
differences and similarities in capacity between healthy and chronically ill children and 
adolescents.  
 Overall results suggest adolescent capacity to consent to research was similar to 
adults, and most strongly associated with their family’s socioeconomic status as well as 
v 
their level of health literacy. These findings contrast starkly with the age-based criterion 
for providing consent currently utilized in assent and consent determinations. These 
findings also provide insights into ways to ethically involve youth in complex biomedical 
research. 
 
James A. Hall, PhD 
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V. Introduction 
Jane Addams wrote, “Action is indeed the sole medium of expression for ethics 
(1902, p. 273).” These words, written over 110 years ago, still ring true today, and are a 
mainstay within the field of social work ethics. This reflection largely concerns the 
vulnerable populations social workers encounter on a daily basis coupled with the field’s 
aim of making a difference in the community. However, it is not enough for social 
workers to consider the implications of action or inaction—both practitioners and 
researchers are part of a multi-generational reiterative process of implementing new and 
innovative ways of making the world a better place for oppressed and disenfranchised 
populations who find themselves broadly labeled as “vulnerable populations” (Frohlich & 
Potvin, 2008). For this reason, the study of vulnerable populations is central to the 
efficacious practice and development of applicable social work theories for better 
advocating for, treating, and understanding those in the greatest need and considered at-
risk (Aday, 1994; Gelberg, Andersen, & Leake, 2000). Studying such populations 
highlights the ways in which social workers are uniquely positioned to understand the 
complex nature of vulnerability and the multidimensional ways in which it can manifest.  
Within social work practice, considerable time is spent discussing how to best 
work with different vulnerable populations, respect their self-determination, and navigate 
the complex systems necessary to advocate for clients. This advocating for vulnerable 
populations is a hallmark of the social work profession, and is one of the primary goals of 
the field. Although numerous methods are used in social work to address vulnerability in 
practice, the same attention has not been paid to research. For instance, the potential 
impact of the utilization of the strengths perspective on the research recruitment process 
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have not been examined. Additionally, within the realm of research, a scant amount of 
data exist demonstrating how social workers are intervening within the research process 
to advocate for the rights of research participants, respect participants’ self-determination 
and autonomy, and do justice by looking at research participation as a right (Elks, 1993; 
John, 2007). 
The present dissertation explored the concepts of vulnerability and capacity 
within the context of research participation, with a specific focus on adolescents’ 
participation. A variety of factors influencing research participation were examined to 
deepen current understanding of the ways in which social work can improve ethical 
recruitment of subjects to studies as well as increase research inclusiveness, build 
stronger community relationships among participants, and enhance the overall quality of 
research.  
Outline 
 The purpose of the following literature review is to outline the ways in which 
different types of vulnerability inform our understanding and application of capacity with 
adolescents. The overarching hope is to clarify the classification of vulnerability in 
human subjects research in the context of adolescent capacity to consent to research. 
Although the intended focus is on capacity as it applies to adolescents, it is important to 
note that many of the issues raised also apply to other vulnerable populations (e.g., the 
mentally ill, the elderly). This review begins by providing functional definitions for the 
terms that will be used throughout, including placing the concepts of vulnerability and 
capacity into a social work context and explaining how and why this topic is of specific 
concern to social work practitioners and researchers. The concept of vulnerability is 
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broad in its application; therefore, a number of conceptual areas will be covered to 
contextualize vulnerability and better understand how capacity is addressed in practice. 
The review concludes with a discussion of the implications of this research for the field 
of social work, with special attention being paid to both practice and theory. 
Definitions 
To be able to discuss adolescent vulnerability and capacity in research, key terms 
must be defined. Due to the multidisciplinary nature of the topic, these terms can have 
various definitions depending on the context; thus, the following section offers the 
definitions of terms and concepts as to how they apply in the present work, namely, 
capacity, vulnerability, adolescence, informed consent, and assent. 
Capacity generally refers to an individual’s ability to make an informed decision 
(Clausen, 1991; Weithorn & Campbell, 1982). In the present work, capacity was 
operationalized through four criteria governing an individual’s ability to give or withhold 
consent. These criteria are based on Applebaum and Roth’s (1982) framework and 
include (1) understanding, which is defined as utilization of relevant information to make 
a decision, (2) appreciation, being able to comprehend the significance of the decision 
(e.g., that the decision truly is one’s own), (3) reasoning, having the ability to manipulate 
information rationally, and (4) making a decision having the ability to communicate 
one’s intended decision. 
Vulnerability in terms of individuals and populations can be difficult to define. 
Vulnerable populations and how to identify them been defined in numerous ways in 
previous studies (Hurst, 2008). The Declaration of Helsinki (1964) defined vulnerability 
as “…an increased likelihood of being wronged or of incurring additional harm.” (p. 4) 
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Similarly, the National Bioethics Advisory Commission (2001) defined vulnerability 
according to participation: Those who are not fully capable of resisting the request to 
become participants—such as prisoners or other institutionalized/vulnerable persons—
should not be enrolled in studies merely because they are easily accessible or convenient. 
This work used the following definition of vulnerability, based on Iltis (2009): “The 
ability to give or withhold informed consent and the likelihood of being misled, 
mistreated, or otherwise taken advantage of in research.” (p.7) 
Vulnerability has been partially addressed at the federal level by the Department 
of Health and Human Services (2009), which offers a non-exhaustive list of potentially 
vulnerable groups, including pregnant women, human fetuses, neonates, prisoners, and 
children. From a regulatory perspective, adolescents comprise both children and adults. 
The Protection of Human Subjects statute (2009) of the US Department of Health and 
Human Services defines a child as “persons who have not attained the legal age for 
consent to treatments or procedures involved in the research, under the applicable law of 
the jurisdiction in which the research will be conducted” (46.402 subpart A). The legal 
age is generally 18 years of age, although underage adolescents can consent to some 
medical treatments (e.g., STD testing). Thus, not all adolescents are considered 
“children” and therefore “vulnerable” according to US research regulations. 
Adolescence refers to the transitional period from childhood to adulthood, 
beginning at the onset of puberty and ending with taking up of adult social roles (e.g., 
work, marriage) and responsibilities (Lerner & Steinberg, 2004). The operationalized 
definition of this term for the present work was that of the United Nations, wherein 
adolescence spans from ages 12–24 years (United Nations, 2012). Note that this range is 
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but one of many utilized in research; it was utilized in the present dissertation because I 
wanted to compare early and late adolescence without regard for the legal status of 
minor/adults. Adolescence was categorized as follows: early (12–14 years), middle (15–
17 years), and late (18–24 years).  
Informed consent is a process potential research subjects undergo and is intended 
to promote and honor autonomy during enrollment into a research protocol (Faden, 
Beauchamp, & King, 1986). This process is a legal requirement ensuring that participants 
are given information about the risks and benefits of participation, how to withdraw, what 
the procedures are, and who they can contact to get more information and assistance 
pertaining to study involvement (Appelbaum, Lidz, & Meisel, 1987). In a research 
setting, the informed consent process is where potential participants exercise their 
decision-making capacity.  
Assent is discussed directly in the federal regulations guiding research and is 
defined as “…a child's affirmative agreement to participate in research. Mere failure to 
object should not, absent affirmative agreement, be construed as assent” (Protection of 
Human Subjects, 2009, 46.402 subpart B). Within the research enrollment process, 
attaining assent follows the informed consent process; however, concerns have been 
raised about the voluntariness of the assent obtained via this process (Kipnis, 2003). 
Specifically, researchers of child and adolescent assent believe that the process of 
attaining assent might in fact mask adolescents’ true desire to participate or abstain from 
research (Kumpunen, Shipway, Taylor, Aldiss, & Gibson, 2012; Scherer et al., 2013).  
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A social work perspective 
Both the professional and academic aspects of social work are inherently 
interdisciplinary and attempt to address a diverse array of topics and vulnerable 
populations using a variety of philosophies and methods. As the social work profession 
continues to grow and diversify to address the needs of the ever-changing social 
landscape, social workers are increasingly being tapped as direct members or consultants 
for interdisciplinary treatment and research teams (Maramaldi et al., 2014). Collaborative 
interdisciplinary care is becoming increasingly common in both acute and chronic care 
cases, as many cases must address a host of tangential issues connected to the illness, 
such as the mental health of the patient or the shifting family dynamics that illness can 
cause (Rothman & Wagner, 2003). Collaborative interdisciplinary teams utilizing social 
workers have been particularly effective within the medical model, and, in addition to 
benefitting patients, have provided social workers with a diversified view of health care 
and treatment (Bronstein, 2003). Academically, these collaborative teams allow social 
workers to participate in and have a direct impact on all facets of research and practice. 
As social workers often provide counsel and advocacy for highly vulnerable populations, 
they are in a unique position to fully understand and respond to a multitude of 
vulnerabilities both clinically and within a research setting. 
Pediatric and adolescent research is of vital importance to advancing our 
understanding of the diseases and behaviors that influence young people, while the 
recruitment of young participants is of similarly vital importance for the advancement of 
such research (Llewellyn-Thomas, McGreal, Thiel, Fine, & Erlichman, 1991). Human 
subjects research is a multifaceted process, with various different contributing variables 
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at play in each stage. A variety of factors affect the decision-making process of whether 
an adolescent will participate in research, and there are key differences between adult and 
adolescent in terms of motivation for participation. An essential factor for social work 
practitioners and researchers to consider is as follows: if we consider vulnerability a 
blanket assignation for all minors, why do we believe that assent (gained after parental 
consent) is necessary? Accordingly, social workers may be poised to better understand 
true vulnerability and its use in research, including how and when it is applied and the 
protections that can be offered to alleviate it. 
As research with hidden and hard to reach populations becomes more accessible 
through the use of technology and enhanced recruiting techniques, the use of highly 
skilled individuals’ with experience in comprehensive assessments will be necessary to 
facilitate ethical research. With additional training and experience, social workers will be 
perfectly poised to step into this role across all types of research and can act as a conduit 
to bridge the perceived gap between assessment, treatment, and research. This 
dissertation presents both a review of a conceptual framework for social workers to 
utilize when working in research recruitment as well as beginning evidence for an 
objective measure of capacity to consent to research which can be used in participation 
decisions as well as a screening measure to identify different needs and vulnerabilities 
one might present in a research recruitment setting. Conceptually, this work seeks to add 
a framework for understanding adolescent vulnerability in research recruitment as well as 
evidence for use of formalized capacity assessment measures in research recruitment.  
.
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VI. Literature Review 
This chapter provides an overview of the literature on capacity using a framework 
of vulnerability that highlights the different ways in which adolescents might be 
considered systematically unable to provide consent. To understand capacity and how it 
can be utilized to enhance clinical trial recruitment, a comprehensive understanding of 
vulnerability is necessary. I first discuss the concept of vulnerability within adolescent 
research as a means to understand the ways in which adolescent populations are 
considered vulnerable. 
Vulnerability and capacity 
Per US federal regulations, vulnerability is currently a blanket term assigned to 
large groups of individuals without recognition of their individual characteristics (C. 
Levine et al., 2004). For instance, merely by not having attained the legal age of consent, 
anyone in the US under the age of 18 is viewed as vulnerable despite the considerable 
literature base suggesting that older adolescents may have similar levels of capacity to 
make decisions as adults (R. J. Levine, 1995; Partridge, 2013; Santelli et al., 1995). This 
propensity to ignore individual characteristics has led to both overuse and misuse of the 
term, systematically eliminating potential participants according to group membership 
rather than their individualized level of actual vulnerability (C. Levine et al., 2004). This 
policy poses problems not only because it excludes potential participants from research, 
but also because it potentially masks people who require meaningful protections despite 
being able to participate. Given the biased and systematic exclusion resulting from this 
use of vulnerability, it is clear that a better understand of capacity, or an individual’s 
ability to make informed decisions, is needed. Improving policies regarding capacity to 
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consent can be considered a primary means of expanding the scope of adolescent clinical 
trial involvement and increasing the safety of health research. 
Discerning vulnerability is further complicated in pediatric research because of 
the circumstances surrounding the decision to participate in research. When making 
decisions about research participation, a number of processes must be evaluated. First, 
the research team must recruit the parents of the child into the study and get them to 
provide parental permission. The requirements for parental permission and assent in the 
context of human subjects research are outlined in the Protection of Human Subjects 
statute, Title 45, Part 46 (2009) and involve multiple disclosures to the subject, including 
the purpose and duration of the research, the procedures involved and if they are 
considered experimental, the risks, a contact for any questions, the fact that participation 
is entirely voluntary, and the fact that declining to participate will not render loss of other 
benefits or treatment (US Department of Health and Human Services, 2009). Second, the 
child must provide his or her assent to participate. This process of acquiring both consent 
and assent is a safeguard to ensure that both parents and children are properly informed 
and willing to participate in the research project. However, this process can cause 
problems when there is a disagreement between parent and child or when parental 
permission is not a meaningful protection for the child (e.g., research on sensitive issues). 
Current regulations primarily give decision-making power to parents based solely on the 
vulnerability assigned to their children. Circumstances wherein minors may be able to 
provide consent without parental permission include research on treatments or situations 
for which the adolescent typically provides consent for themselves, such as the diagnosis 
or treatment of sexually transmitted diseases (STDs), contraceptive services, prenatal 
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care, substance abuse treatment, and mental health treatment (Boonstra & Nash, 2000; 
Guttmacher Institute, 2014). These minor consent laws vary by state. For example, 
screening and treatment for STDs is permissible in all 50 states without parental 
notification or permission, but only 34 states have explicit laws related to consent to 
contraceptive services (Guttmacher Institute, 2014).  
These power differentials between parent and adolescent as well as researcher and 
adolescent are of importance to social workers and other professionals that work with 
adolescents. For instance, depending on how adolescents and their parents are 
approached in the recruitment process, shared decision-making can be reduced by 
researchers automatically deferring to the parent. Although generally accepted practice, 
this poses risks to adolescents’ emerging sense of autonomy, self-determination, and 
justice and can ultimately reduce their involvement in the decision making process. 
Furthermore, it may pose specific problems for clinicians and researchers in ethically and 
effectively interacting with adolescent participants. During later adolescence, emphasis 
needs to be placed on supporting growing autonomy and responsibility. This concept is 
respected and given full weight when making treatment decisions, especially for sensitive 
topics (e.g., STD screening and treatment, pregnancy, mental health treatment, substance 
abuse treatment) (Hill, 2011). The explicit distinction between when parental consent is 
needed and when it can be waived is a sign that even within such a complex regulatory 
system it is unclear why and when every person under the age of 18 is considered 
vulnerable. Understanding this complex system and its impacts on clinical care and 
research recruitment can help social workers better navigate the systems as well as 
advocate for their adolescent clients. 
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A framework of vulnerability 
As noted above, vulnerability can be challenging to operationalize. One approach 
is to suggest that every individual has some form of vulnerability and therefore requires 
specialized protection in certain situations. However, such an approach may not be 
reasonable, being too cumbersome and time consuming. Another approach is to identify 
specific vulnerable groups. However, this approach has the potential to stereotype said 
groups, ultimately acting as a form of oppression that does not adequately account for 
individual differences (C. Levine et al., 2004). A third alternative is to examine the 
characteristics and situations that may lead to vulnerability, such as Kipnis’s (2003) 
framework, which proposed to identify and categorize differing manifestations of 
vulnerability in pediatric research participants. This framework allows investigators to 
examine the types of vulnerability and their relevance to research. Within this framework, 
seven main types of vulnerability can influence adolescent informed consent: 
o Incapacitational, or an individual’s ability to make decisions using the 
information at hand; 
o Deferential, wherein decisions are deferred to other professions or 
others in power; 
o Juridic, wherein someone has legal authority over an individual’s 
ability to make his or her own decisions; 
o Allocational, wherein factors such as education and poverty may 
impact an individual’s decision; 
o Medical, which refers to when a person feels obligated to participate in 
research due to a health condition for which there are few or 
unsatisfactory cures; 
o Situational, which refers to when someone has an illness that prevents 
necessary deliberation needed to make an informed decision to 
participate; and 
o Social, which involves being the member of a group with a history of 
being socially devalued.  
(Kipnis, 2003) 
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 This list represents the range of possible characteristics that may make an 
individual vulnerable. It is important to note that at any one point in time any number of 
these types of vulnerability can affect an individual and may be highly dependent on the 
situation. For this reason, it is crucial that social workers more closely examine how 
vulnerability is formulated, evaluated, and addressed within research settings (Kipnis, 
2003). The most important form of vulnerability for making decisions about informed 
consent is incapacitational vulnerability. For adolescents, the ability to give informed 
consent rests mainly on the idea of capacity to make that decision, and is an aspect of 
research participation decision making unique to adolescents.  
Capacity and incapacitational vulnerability 
Capacity has been identified as the most important issue in pediatric research 
ethics (National Commission for the Protection of Human Subjects of Biomedical and 
Behavioral Research, 1977) as well as a critical issue in research with adolescents 
(Berman & Field, 2004). The issue of capacity is of specific concern in the recruiting and 
consenting process represents a major barrier to recruitment of adolescent participants 
(Kipnis, 2003). Because ethical standards require an individual to be free of undue 
influence and coercion and limit use of unjustifiable pressure and manipulation, specific 
attention must be paid to how researchers interact with potential adolescent research 
participants (Department of Health, 1979). However, the inclusion of social workers and 
social work perspectives in pharmaceutical or clinical trial research may bring up issues 
that directly conflict with the NASW Code of Ethics. Within the Code of Ethics (2008), 
one section outlines that the social worker’s duty is to obtain informed consent that does 
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not violate the terms and laws specified in both the Code and the Belmont Report (1979), 
where the concept of informed consent is thoroughly discussed.  
A variety of factors contribute to the decision making process of whether an 
individual will participate in a research study or not (McGregor, Ott, Lally, & Zimet, 
2014). Two factors that ultimately coexist in a research participant are willingness to 
participate (WTP) and capacity to consent to research (Broome, 1999). These two ideas 
are similar and directly related, but cover different facets of this decision making process 
(Spigarelli, 2008). WTP is associated with the general outcome of the deliberations of a 
potential subject. A person will either indicate that they want to participate or will 
indicate that they do not want to. This dichotomous decision (which can be revised as the 
study goes on) is merely an outcome and does not include any information about the 
process that an individual goes through to reach this decision. Therefore, to more fully 
assess the decision making process of the individual, we utilize the concept of capacity as 
a measure to ensure that an individual has not only the WTP, but also the ability to weigh 
the tangible pros and cons of participation (or not participating) along with the more 
intangible risks and benefits. Viewed in this light, WTP would be the simple outcome of 
the complex interplay of decision making processes that form the capacity to consent to 
research. Whereas a monetary incentive could instill a high WTP, it could lead to an 
ethical grey area of exploitation and coercion in terms of consent (Dempsey, Back, 
Waldrop, Jenkins, & Brady, 2008; Klitzman, 2013).  
The literature on research recruitment has increasingly focused on the ethical 
concerns of providing incentives, whether incentives have any impact on study 
recruitment, and the determinants of research participation (Singer, 2003; Singer & 
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Couper, 2008; Verheggen, Nieman, & Jonkers, 1998). With such an increased focus on 
the methods used to improve recruitment and retention, information is lacking on the 
effects of systematic exclusion and reasons as to why individuals decline to participate.  
Within clinical research, ethical standards backed by institutional review boards 
(IRBs) can directly affect researchers’ limits on what they can and cannot do to recruit 
participants (Grant & Sugarman, 2004; Holden, Rosenberg, Tuhrim, & Brenner, 1993). 
Although this oversight provided by IRBs is intended to protect research participants, 
certain circumstances might arise wherein IRB protections do not specifically protect a 
population, but indirectly act to hinder research of populations that are at risk and 
therefore in great need of clinical research (Morris, 2012). Due to concerns of coercion 
and posing a greater than minimal risk to participants, many within the research 
community are concerned about what populations can be directly studied and what 
methods researchers can use to increase participation rates (Grant & Sugarman, 2004; 
Singer & Couper, 2008).  
Deferential and juridic vulnerability 
The deferential and juridic types of vulnerability span all ages, but are particularly 
likely among adolescents because of their power differentials with parents, researchers, 
and other adults (Kipnis, 2003). Specifically, parents’ role in the decision making process 
coupled with adolescents’ lack of legal standing to provide their own assent make it 
especially difficult to separate parental motivations from adolescent motivations, and 
even harder to know if adolescent assent is given freely (Brody, Turner, Annett, Scherer, 
& Dalen, 2012). Furthermore, within clinical research trials with adolescents, a number 
of factors affecting participation decisions do not apply when parents must make the 
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decision for their child compared to when they make it themselves (Berman & Field, 
2004). An increased focus on the capacity of adolescents independent of parental consent 
could provide not only validation of adolescents’ assent, but also further pinpoint what 
motivators are at play and how adolescents view any potential risks involved in the 
research.  
Research in this area has examined the decision-making of both parents and their 
children together as well as how adolescents make decisions independently, and has 
shown that parents have higher levels of risk aversion and that all groups cite some form 
of altruism as a main reason for participating (Brody, Annett, Scherer, Perryman, & 
Cofrin, 2005; Llewellyn-Thomas et al., 1991; Pasternak, Geller, Parrish, & Cheng, 2006). 
Recent research (specifically that within the field of adolescent asthma treatment) has 
focused on the differences in motivations between parents and adolescents that choose to 
participate in research. Brody and colleagues (2012) found that adolescents were much 
more likely to participate in research if they felt a strong connection with the research 
team. Furthermore, adolescents who did feel such a connection were more likely to 
perceive financial compensation as a motivating factor. This finding is divergent from the 
adult findings, which indicate that parents are much more concerned about safety, how 
much time participation will take, and being used as a “guinea pig” (Brody et al., 2012; 
Epstein, 2007; Swanson & Ward, 1995). Additionally, Morris (2012) found a strong 
indication that adolescents place less emphasis on risk than do their parents (Morris, 
2012). As previously posited, this points to a higher prevalence of protection concerns 
within parental decision making overall instead of a modified risk/benefit calculation 
when adolescents are involved.  
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 Within newly emerging research on adolescent and parent decision making in 
clinical research, it is notable that researchers who place greater emphasis on the 
development of rapport with pediatric participants will not only do better in securing 
parental consent, but will do significantly better in securing meaningful adolescent assent 
with those effects lasting throughout the study, thereby increasing retention in 
longitudinal studies. A tool for measuring adolescent capacity paired with good rapport 
could act as an additional indicator of the individual’s ability to not only provide assent, 
but also fathom the necessary commitment to participation in a longitudinal study. 
Additionally, when designing a research protocol, it is of increasing importance to know 
the intended audience. Studies focusing on adults as individual actors will have different 
recruitment protocol needs than will studies focusing on adolescents or parent–adolescent 
dyads. An increased focus on adolescent capacity and the decision-making logic of 
different target populations in participating or declining to participate will help research 
teams recruit more effectively, increase subject retention, and hopefully help reduce the 
likelihood of deferential and juridic vulnerability influencing study participation.  
Allocational vulnerability 
Substantial concerns have been raised about the ethics of providing monetary 
incentives for research participation, and these incentives are a major conversation topic 
in the context of allocational vulnerability (Kipnis, 2003). When using a monetary 
incentive for research participation, a gauge of capacity is critical. Researchers tow an 
ethical line when paying participants, making the understanding of what drives the 
decision to participate of great importance to ethical research practice. A number of 
authors have challenged the use of monetary incentives as an ethical research practice, 
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claiming incentives can act as a form of coercion in human subject recruitment (Holden 
et al., 1993; Singer & Couper, 2008; Verheggen et al., 1998; Yancey, Ortega, & 
Kumanyika, 2006). Despite this sharp division on the use of monetary incentives, 
numerous attempts have been made to develop guidelines for determining how much and 
in what form monetary incentives should be utilized. One generally accepted guide 
developed by Fry, Hall, Ritter, and Jenkinson (2006) states that research payments are 
ethically permissible in most circumstances, but need to be closely monitored to ensure 
that the payment is not functioning as an inducement that exacerbates harm or creates 
additional risks for the participant.  
 The notions of coercion and undue influence have been widely discussed within 
the research ethics literature (Grady, 2001; Wertheimer & Miller, 2008). Concerns over 
the coercive effect of payments have persisted in the adult research ethics literature, 
particularly regarding how payment undermines autonomy and the requirement for 
voluntariness (Macklin, 1989), discourages people to freely opt out due to the financial 
necessity of participation (Emanuel & Miller, 2007), and reflects a general sense of 
paternalism (Miller & Wertheimer, 2007). Incentives are intended to act as a means of 
compensating people for their time and reimbursing them for any expenses they might 
incur during the study period (Klitzman, 2013). An argument follows that if the 
utilization of monetary incentives is seen as necessary it is important that researchers can 
analyze the decision making process and participants’ capacity. The potential risk for an 
individual to participate out of financial desperation despite not being comfortable with 
the risk or without properly considering the risk due to the incentive is high. This point 
when an incentive crosses the line from reimbursement to coercion or an undue influence 
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is crucial to identify (London, Borasky, Bhan, & Ethics Working Group of the HIV 
Prevention Trials Network, 2012; Wertheimer & Miller, 2014).  
Using financial incentives to recruit adolescents and their parents can be an 
effective strategy as long as the incentives do not induce behavior that the participant 
would not have engaged in otherwise (Singer & Couper, 2008). However, as previously 
mentioned, these practices should be closely monitored for ethical concerns. Indeed, 
families with chronically ill children may greatly benefit from any form of monetary 
incentive. Furthermore, approximately 40% of families of children with special 
healthcare needs experience financial burden due to the child’s condition (Kuhlthau, Hill, 
Yucel, & Perrin, 2005). Although this statistic provides ample support for a monetary 
incentive for this particular population, researchers should always be careful to ensure 
that the incentive is not exploited and that increased risk is not accepted by the subject in 
exchange for financial incentive. A tool for assessing capacity while simultaneously 
engaging in the current methods of continually monitoring the ethical use of incentives—
namely, evaluating protocols for favorable risk-benefit ratios, using enhanced consent 
methods, and ensuring that highly vulnerable populations are not systematically enrolled 
in high-risk/low-benefit research—would be beneficial (Emanuel, 2005). 
Medical and situational vulnerability 
Medical vulnerability is defined as participants’ feeling of obligation to 
participate in research due to a health condition for which there are few or unsatisfactory 
cures (Kipnis, 2003). This type of vulnerability is especially important to consider in 
clinical research due to its reliance on sick individuals to participate in clinical protocols. 
Similarly, situational vulnerability refers to when an individual has an illness that 
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prevents them from engaging in the necessary deliberation for making an informed 
decision to participate. These types of vulnerability often coincide in pediatric and 
adolescent research because of the necessity to quickly enroll patients in clinical 
protocols after diagnosis to enhance the likelihood of a positive outcome from treatment. 
Adolescents and families dealing with chronic illness or special health needs tend 
to be treated by not only medical professionals, but also social workers. Medical 
vulnerability is at its highest in research on experimental therapies for adolescents with 
life-threatening conditions that have no approved satisfactory remedies (Kipnis, 2003). 
This type of vulnerability is of particular concern to studies on adolescents and their 
families, because both groups could feel as though they have no choice but to enroll in 
potentially risky trials. Similarly, with situational vulnerability, the adolescent and his 
parent may be pressured into a clinical research study without having the time to truly 
consider the risks and benefits of participation. For these types of vulnerability, social 
workers can be utilized to provide a professional opinion on capacity, quality of consent, 
and assent. Social workers can also maintain an ongoing professional relationship with 
the subject and/or family to monitor for any possible coercion by external motivators 
such as financial compensation or other ethical compromises. Additionally, the strain of 
chronic illness increases the risk for depression, and families may require additional 
counseling to assist in coping and stress management (Katon, 2011; Pinquart & Shen, 
2011).  
 Chronically ill populations receive a great deal of attention within the medical 
ethics literature (Beresford & Sloper, 2003; Broome, Richards, & Hall, 2001), and this is 
especially true with regard to chronically ill adolescents’ participation in clinical trials. 
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Less research is available on adolescents’ experiences in chronic illness research; 
however, within the court of public perception, researchers may be thought of as 
exploitive by conducting studies with this population, especially when results are not 
quickly and directly shared with participants (Fernandez et al., 2007). In Kipnis’s (2003) 
discussion of medical vulnerability and coercion, he is very clear that chronically ill 
individuals are not inherently being exploited or taken advantage of. Although 
disagreement exists as to how and what specifically constitutes exploitation in this sense, 
feedback from research participants suggests that they feel like they are able to give back, 
to provide assistance to the medical community in hopes of one day finding a cure for 
their disease, and that they do hold out hope that enrollment in a new research protocol 
might cure them of the disease (Brody et al., 2005; Pasternak et al., 2006). In this sense, 
research staff should work with subjects to ensure they are completely informed of the 
risks as well as the realistic benefits that the subject may experience, including the fact 
that participation may not yield a change in medical condition (Rice & Broome, 2004). A 
more comprehensive capacity measurement and consenting process coupled with 
continued social work involvement with participants would hopefully lead researchers to 
redesign their clinical trials to extend treatments for individuals showing positive results 
for experimental therapies. This change in approach would drastically reduce the 
prevalence and likelihood of medical and situational vulnerability for adolescent research 
participants. As a first step, the present research project examined the role of chronic 
illness in decision making. 
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Social vulnerability 
 Although there are few data on adolescent ethnic minority trial participation, 
larger patterns of adolescent discrimination have been reported across all ethnic groups 
specifically within educational settings (C. B. Fisher, Wallace, & Fenton, 2000). These 
larger patterns of feeling discriminated against by those in power have been discussed 
primarily in research on adults; however, they have been brought up within adolescent 
research as well (C. B. Fisher et al., 2002; McLoyd, 1998).  
Adult research shows higher minority group enrollment in Phase I clinical trials 
than in Phase III trials by a considerable margin, suggesting that minorities may be 
bearing more risk and reaping less benefit (Corbie-Smith, Thomas, Williams, & Moody-
Ayers, 1999; J. A. Fisher & Kalbaugh, 2011; Schmotzer, 2012; Swanson & Ward, 1995). 
Although a prima facie evaluation of high minority involvement in Phase I studies may 
seem to run contrary to the notion of a bias in clinical research, deeper analysis of the 
risks and benefits of Phase I versus Phase III clinical trials provide more insight into the 
depth and nature of institutional bias. Comparing study types shows that minorities are 
typically targeted for Phase I studies and that the differences in their participation rates 
between Phase I and Phase III trials underscores an inherent problem within the research 
community (J. A. Fisher & Kalbaugh, 2011, 2012). Utilizing lower socioeconomic status 
(SES) and minority participants for high-risk studies, yet not offering them the 
opportunities to participate in the Phase III trials that could potentially improve their 
health, illuminates a major research ethics issue (J. A. Fisher & Kalbaugh, 2012). 
These multiple vulnerabilities are an area in which social workers can 
substantially contribute to participant protections, particularly those populations, such as 
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adolescents, who have been identified as “vulnerable.” Social workers can evaluate not 
only the potential for coercion, but also for the overlapping social and societal 
considerations that might influence an adolescent and his/her parent/guardian’s ability to 
make an informed decision. There are myriad ways in which potential subjects in a 
research protocol could be greatly affected by a legacy of social devaluation; for instance, 
African American parents of minors may experience considerable distrust because of a 
long history of abuse by researchers (Shavers-Hornaday & Lynch, 1997). This legacy can 
in turn cause conflict during the consent and assent process, ultimately limiting the 
number of viable candidates available for research. Additionally, when evaluating 
minors’ capability to provide informed consent, their opinions and rights may be 
squelched by overprotective IRBs that are unaware of the protections available for 
minors, researchers who shy away from “hot topics” and sensitive subject research with 
vulnerable populations, or funding mechanisms ill-equipped to accurately assess the 
value and merit of research with minors (Risjord & Creenberg, 2002). 
Responding to vulnerability occurring as a result of being socially devalued, for 
both adolescents and adolescent–parent pairs, seems uniquely suited to social workers 
with training in family systems or adolescent development. A grounded understanding of 
how oppression and vulnerability can affect decision making enables a social worker to 
work with a family to help dispel inaccurate information or misunderstanding and 
provide greater detail on the topic at hand in a vernacular appropriate for the situation. 
Concerns have been raised that spending an excessive amount of time discussing a study 
with a family may burgeon into coercion. In other words, researchers, in an attempt to 
enroll an individual into a study, may provide a one-sided view of the study that 
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erroneously convinces a parent to provide consent. However, available evidence on the 
subject provides initial evidence that such lower levels of transparent information may 
actually lead to a decrease in parents’ willingness to participate (Lally et al., 2014). 
Additional efforts to assess capacity may help to not only provide candidate participants 
with better information about the study (i.e., both more comprehensive and more clearly 
delivered), including the risks and benefits of participation, but also provide researchers 
with more information about why candidates may be unwilling to participate (Condon, 
1986; Conroy & Harcourt, 2009). This is where social workers and a social work 
perspective could be helpful by utilizing a comprehensive evaluation framework 
including a capacity assessment, social workers may be poised to provide information 
while assessing potential participants fit for studies, toeing a fine line between educating 
and coercing. Furthermore, it could improve the recruitment process overall by providing 
more information on the potential problems of recruitment, thereby helping recruit 
participants to a project where they may be able to provide significant and meaningful 
contributions. 
Summary of vulnerability  
Capacity emerges as a key concept for understanding and contextualizing the 
different forms vulnerability. Utilizing the Kipnis (2003) framework (Figure 2 provides a 
foundation for understanding the potential problems of recruitment. Indeed, it is not until 
these factors are considered in relation to each other that a hierarchical model with 
capacity functioning as the dominant concept emerges. Although the other six forms of 
vulnerability are important to assess and monitor, capacity is ultimately what will 
determine the impact those other factors have on an individual’s decision-making 
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process. For this reason, the primary focus of this research was the role of capacity in 
adolescent decision making. By better understanding how capacity functions within the 
research recruitment process, social workers and researchers will be better able to assess 
the effects of the various other forms of vulnerability.  
 
 
Figure 1. Conceptualization of Kipnis’s (2003) vulnerability framework and 
requirements for consent 
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VII. Methods 
Purpose and aims 
 The overall objective of this research project was to evaluate adolescents’ 
capacity to consent to participate in research. The purpose of the present study was to 
adapt an adult capacity assessment instrument for 12- to 24-year-olds with chronic illness 
to assess their decision-making capacity to consent to research. More specifically, the 
aims of this study were to: 
1. Identify the predictors of capacity, including (a) chronic illness, (b) health 
literacy, (c) developmental and demographic factors, and (d) previous research 
participation; 
2. Compare the key predictors of capacity between chronically ill adolescents and 
healthy adolescents; and 
3. Compare the predictors of capacity between minors (<18) and young adults with 
chronic illness.  
Participants 
Participants were adolescents aged 12–24 years. Primary inclusion criteria were 
being within this age range and the ability to read and speak English. Exclusion criteria 
included individuals who were obviously intoxicated or under the influence of a 
substance as well as individuals obviously lacking the capacity to understand the study 
procedures due to severe medical illness or significant cognitive impairment. Such status 
was assessed by the parent (if the participants were minors) or the interviewer according 
to the participants’ ability to understand and give informed consent for the study. 
Individuals were recruited into the study without consideration of their chronic illness 
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status, which was only discovered after completion of the initial study demographic 
survey.  
Recruitment and enrollment 
Adolescents and young adults ages 12-24 were recruited from primary care 
clinics, schools, and the community. Research staff contacted teachers and school 
administrators, program directors, youth workers, physicians, and clinic administrators to 
ask permission to recruit youth from the relevant institutions. This approach allowed 
recruitment of adolescents across a range of sociodemographic characteristics and life 
experiences. Furthermore, this recruitment approach was similar to that used for clinical 
and behavioral research with healthy adolescents. The IRB approved the research 
protocol. Adolescents provided consent, and parents/guardians provided permission for 
those under 18 years of age. 
Adolescent consent and parental permission. Prospective participants who 
were minors (including those recruited from schools, clinics, or who were self-referred) 
were given a copy of the study consent form, either in person or via email, for their 
parents to sign. Parents were provided with the researcher’s phone number and e-mail 
address so that they could ask questions. Adolescents who returned to their school, clinic, 
or other study site with a signed consent form then met with the researcher, who reviewed 
the study information and consent form with the prospective participants in a private 
room. Interested participants were then given a consent form to sign themselves and were 
provided with a copy of the form. Parents were encouraged to visit the study site and 
participate in this consent process if able. 
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Protection against risk. Protection against risk was accomplished by thorough 
training of the research staff; careful orientation of potential subjects regarding the 
nature, risks, and benefits of the study; strict adherence to study protocols; and regular 
surveillance for adverse events. The procedures utilized had no more risk than did normal 
daily activities an adolescent might experience.  
Participants’ confidentiality was protected by omission of individual identifiers 
associated with their study responses. Data were stored in a password-protected database 
containing only study numbers. Separate password-protected files containing individual 
names and contact information (e.g., cell phone numbers) were maintained for 
administrative purposes to re-establish contact with participants who were recruited from 
sites participating in the test-retest reliability portion of the study. These computer files 
were maintained within the offices of the principal investigator. Access to any files was 
limited to research personnel.  
Procedure 
A 60- to 90-minute interview, involving both interviewer-administered and self-
administered questionnaires, was used to assess participants’ capacity to understand and 
consent to research and related factors. 
Capacity for consent was assessed using the MacCAT-CR, a standardized 
measure of capacity, in a semi-structured interview format, along with three consent 
forms for various types of research study: a randomized controlled trial of a new 
headache medication, a biobanking study, and a sexual behavior and surveillance study. 
These three studies were chosen because they represent the range of study types in which 
adolescents are typically enrolled. The order of consent form presentation was 
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randomized for each participant to minimize possible exposure bias; this was done upon 
enrollment by randomly assigning participants to one of three groups with differing 
presentation orders of the three consent procedures. Participants were asked to read the 
consent form on their own, and then go through the typical consent procedure with the 
researcher for that individual form. 
 The interviews were conducted in a private location of the participant’s choosing, 
and participants were reminded that they could refuse to answer any question for any 
reason. Following assessment of eligibility, enrollment, and informed consent, 
participants’ recruitment site was noted and they were given the self-administered survey 
collecting demographic (age, ethnicity), developmental (education), and medical 
information (diagnoses, medications, treatments, hospitalization); 12- to 13-year-old 
participants were given a different questionnaire that did not include items about sexual 
activity. Next, the Rapid Estimate of Adult Literacy in Medicine (REALM), MacCAT-
CR, Adapted University of California, San Diego Brief Assessment of Capacity to 
Consent (UBACC), and Evaluation to Sign Consent Form (ESC) were administered by 
the researcher; audio recordings were made of the MacCAT-CR, UBACC, and ESC 
administrations.  
Main measurement instruments 
MacArthur Competence Assessment Tool for Clinical Research (MacCAT-
CR). The MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR) 
is a comprehensive assessment tool for adult capacity assessments (Appelbaum & Grisso, 
2001). There are emerging data supporting its use with adolescents (Hein, Troost, & 
Lindeboom, 2014; Hein et al., 2012; Koelch, Prestel, Singer, Schulze, & Fegert, 2010). 
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The effectiveness of the tool stems from its focus on the four criteria thought to be 
required for consent: evidence of choice, factual understanding of the issues, rational 
manipulation of information, and appreciation of the nature of the situation (Appelbaum 
& Roth, 1982; Kim, 2010; Turrell, Peterson-Badali, & Katzman, 2011). Use of the 
MacCAT-CR with chronically ill adults has been shown to be a reliable and effective 
way to assess patient capacity for clinical trials (Karlawish, Casarett, & James, 2002). 
This project sought to evaluate the effectiveness of the MacCAT-CR on chronically ill 
children and adolescents, as these are the pediatric populations most likely to participate 
in clinical trials research (Koelch et al., 2009). The research available on the MacCAT-
CR’s effectiveness in adult populations with waning cognitive capacity suggest that the 
measure should be sensitive enough to capture evolving capacity (Karlawish, et al., 2008; 
Kim & Caine, 2014; Palmer et al., 2005). 
Specifically when assessing adolescent capacity to consent we were interested in 
how social/behavioral factors played into an adolescents ability to consent, and if there 
was a difference in those relationships between healthy and chronically ill participants. 
There is emerging information on the association between health literacy, family 
affluence, and age on capacity, and we we’re interested to see how these factors would 
impact capacity assessment scores on the two different adolescent populations. 
REALM 
Health literacy has been identified as one of the most important emerging 
constructs in health care communication (Dumenci, Matsuyama, Kuhn, Perera, & 
Siminoff, 2013), and is currently viewed as a key factor in determinates of health care 
utilization and outcomes (Sentell, Baker, Onaka, & Braun, 2011). The REALM is one of 
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the highest utilized assessments to assess health literacy (Berkman, Sheridan, Donahue, 
Halpern, & Crotty, 2011).The REALM consists of 66-items and is currently the most 
utilized test of health literacy in research settings (Dumenci et al., 2013). The 66-items 
administered take less than 5-minutes to administer and produce a raw score than can be 
quickly converted into five different reading grade equivalencies. The REALM has been 
found to correlate well with the WISC Verbal IQ score. 
FASII 
The family affluence scale II is a self-reported measure that has been validated for 
use in adolescents and is considered to be a more accurate measure of adolescents 
perceptions of SES than traditional self-report measures (Boudreau & Poulin, 2009; 
Boyce, Torsheim, Currie, & Zambon, 2006; Currie, Elton, Todd, & Platt, 1997; Currie et 
al., 2008). Traditional SES scales administered to adults were found to be inaccurate 
when utilized with adolescents due to differences in adolescents’ perceptions of SES and 
lack of knowledge of common measures of SES, such as family income, parent 
education, or enrollment in federal anti-poverty and benefit programs for lower income 
families (e.g. Medicaid). Development of the FASII attempted to identify related 
questions that would be easy to know and articulate while also corresponding directly to 
actual SES of the larger family unit. The FASII is a quickly administered tool that 
focuses on objective statues that exist within households; does the respondent have their 
own bedroom, how many cars does the family have, how many vacations a year does the 
family go on, and how many computers does the family own. These four items form a 
scale that ranges from 0-9 with 0-2 corresponding with low affluence, 3-5 with middle 
affluence, and 6-9 indicating high affluence (Boyce et al., 2006). 
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Statistical analysis 
Analysis of data pertinent to the specific aims of the study began with a 
description of the sample and its overall capacity in terms of the MacCAT-CR and other 
measures. Then, using cross-tabulations and regression models, we identified the age-
related and other correlates of research decision-making capacity in adolescents. The 
MacCAT-CR scores were compared across the different consent procedures.  
The psychometric properties of the MacCAT-CR were assessed as well. Criterion 
and convergent validity were evaluated through comparison to clinical interviews and 
other commonly used capacity assessment tools (UBACC and ESC). Inter-rater reliability 
was assessed to ensure homogeneity in scores across all items. Regression analyses were 
utilized to evaluate the predictors of overall MacCAT-CR scores. Correlations and 
ANOVA will also be utilized assess association to compare groups.  
Statistical analyses were performed with SPSS version 23. Demographic 
characteristics and initial bivariate correlations between the main study measures were 
analyzed utilizing Pearson χ2, Pearson correlations, ANOVA, and t tests. Receiver 
operating characteristic (ROC) curves were utilized to evaluate the performance of the 
capacity assessment tools to determine cutoff scoring for assigning capacity to determine 
the predictors of a binary classification of capacity (i.e., capacity/no capacity). 
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A Framework for Understanding Vulnerability in Research with Adolescents 
As evidenced from above, vulnerability can be remarkably challenging to 
operationalize in related research. One approach would be designating every individual as 
having some form of vulnerability (Handmer, 2003) and therefore requiring tailored 
protection in certain situations. However, this might not be a reasonable definition 
because it is too cumbersome and time consuming to measure. Another approach is to 
identify specific vulnerable groups. However, this approach has the potential for 
stereotyping, thereby ultimately acting as a form of oppression term not adequately 
accounting for individual differences (C. Levine et al., 2004). A third alternative, which 
is perhaps the most suitable to date, is to examine the characteristics and situations that 
may lead to vulnerability for each specific study. Kipnis (2003) developed a framework 
(Figure 1) of vulnerability to identify and categorize its differing manifestations in 
pediatric research participants. This framework gives researchers the ability to clarify 
what types of vulnerability might influence recruitment for their research projects. Kipnis 
suggests that vulnerability has seven main forms, as follows: (1) incapacitational, or an 
individual’s ability to make decisions using the information at hand (i.e., their capacity); 
(2) deferential, or when decisions are deferred to other professions or others in power; 
juridic, when someone has legal authority over an individual’s ability to make his or her 
own decisions; allocational, wherein factors such as education and poverty may impact 
an individual’s decision; medical, which refers to how an individual feels obligated to 
participate due to a health condition for which there are few or unsatisfactory cures; 
situational, or when someone has an illness that prevents them from engaging in the 
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necessary deliberation for an informed decision to participate; and social, or being a 
member of group with a history of being socially devalued (Kipnis, 2003). 
It is important to note that at any one point in time, any number of these types of 
vulnerability could affect an individual and may be highly dependent on the situation. For 
this reason, it is crucial that social workers more closely examine how vulnerability is 
formulated, evaluated, and addressed. In assessing vulnerability, capacity, and informed 
consent, social workers have a unique training and perspective that could allow them to 
play a useful role in protecting research participants (Kipnis, 2003). The most important 
form of vulnerability for social workers to consider in making determinations about 
informed consent is arguably incapacitational vulnerability. For adolescents, providing 
informed consent relies mainly on the idea of a capacity to make that decision, which is 
an aspect of decision making for research participation unique to adolescents. For this 
reason, a social work perspective of the seven types of vulnerability should seek to 
conceptualize incapacitational vulnerability, or capacity, as the overarching variable from 
which all other forms of vulnerability manifest. 
Illustrating the Types of Vulnerability in Practice 
As noted in the previous section, multiple types of vulnerability may be at play at 
one time and simple group membership should not be an identifying factor. Social 
workers can play a role by identifying the type of vulnerability and take a strengths based 
perspective in supporting that vulnerability. Starting with the overarching concept, 
attempting to gain greater insight into adolescent capacity would provide social workers 
in a research setting with a better idea of how well the potential research participant 
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understands the information being presented and how he/she has integrated that new 
knowledge into the existing frameworks of understanding that he/she already possesses.  
In a research setting, adolescents who lack capacity may not be able to tell 
research staff what the risks and benefits of their participation are. Specifically, they 
might be unable to recall or understand what is expected of them if they choose to 
participate in the study; beyond this, they might be unaware that they have a choice to 
participate or be unable to make that choice based on the information provided. In these 
circumstances, it is ethically justifiable to exclude these adolescents from the study on the 
basis that they do not have adequate understanding of the relevant information needed to 
participate. Conversely, this may be the opportunity to provide enhanced information on 
the study procedures and help the potential participant to come to a decision. Deciding 
whether to eliminate or provide further information requires careful balance between 
overprotectiveness and coercion. It would help to identify specific procedures for such 
situations early on in protocol development.  
After decisions have been made about whether an adolescent has capacity, 
additional steps can be taken to identify other types of vulnerability that might affect the 
potential participant’s experience in the research setting. Adolescents with deferential and 
juridic vulnerability may feel compelled to participate based on relationships and 
perceived expectations from the research staff, parents, doctors, etc. Addressing these 
two types of vulnerability would require finding ways to reduce or eliminate the 
perceived pressure on the potential participant to help him/her feel as though he/she has a 
voice in the decision making process. Such methods of reducing deferential and juridic 
vulnerability might include common language explanations that let adolescents know that 
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no one expects anything of them; that it is completely their decision on if they want to 
participate; and that if they decide that they do not want to participate or change their 
mind about participating in the future, it is completely permissible and will have no 
impact on their relationship with the medical team, research staff, etc. The most 
important issue to be aware of with such types of vulnerability is that due to their status 
as minors, their parents’ presence, and the perceived power differential inherent between 
research staff and participants, adolescents will always feel a baseline level of 
compulsory participation. Social workers are ideally positioned to screen for deferential 
behavior that shows misalignment between the preferences of the adolescent and what is 
expected of them. Throughout the informed consent process, social workders skills in 
building a rapport with the potential participant can help better assess for the presence of 
deferential or juridic vulnerability.  
Concerns of coercion are common in all types of human subject research 
(Largent, Grady, Franklin, Miller, & Wertheimer, 2012; Oakes, 2002), and this fear is 
compounded when considering adolescent participation in research (Brody & Waldron, 
2000). Kipnis’s (2003) framework allows for social work researchers to examine the 
issues of perceived power differentials and possible financial inducement more deeply, to 
truly consider the division of benefits received as well as the fairness of the situation as a 
whole. Issues of allocational vulnerability go far deeper than remuneration for research 
participation, and defining, identifying, and correcting this type of vulnerability provides 
one of the greatest challenges to researchers looking to design ethically defensible 
research protocols with adolescents. However, it is this difficultly that plays into social 
work’s natural strength to quickly assess and remedy issues with power imbalance, 
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resource allocation, justice, and fairness. Within the realm of allocational vulnerability, 
concerns over payments functioning as an inducement should be considered; however, a 
broader focus on the just recruitment of adolescent subjects should consider access to 
research, fair compensation for time and expertise, and ensuring that the target group of 
study is characteristically similar to the group that would benefit from the research. Ways 
of controlling for this type of vulnerability include conscious research design as well as 
enhanced interactions between research staff, parents, and adolescent participants.  
The medical and situational types of vulnerability are of concern in adolescent 
research because they present a potential lack of time and available options to make an 
informed decision (Kipnis, 2003). This is particularly true with adolescent cancer 
diagnoses, where the only option for treatment might be a therapeutic trial that needs to 
begin immediately on diagnosis. In this case, both the medical and situational conditions 
may cause adolescent and their parents to feel forced into a decision because of such a 
lack of time or options. However, this exigency coupled with the overwhelming nature of 
such a sudden or traumatic situation fits well into medical social work’s natural role as 
communication facilitators and enhancers. When medical and situational vulnerabilities 
are of concern, social workers are a necessary force to ensure that all parties are given as 
much helpful information as possible in a caring and empathic manner. It is social work’s 
specific focus on the role of the individual within a large series of connected systems that 
can help to alleviate these tensions. 
Summary of Vulnerability 
Capacity emerges as a key concept in understanding and contextualizing the 
different forms vulnerability. Utilizing Kipnis’s (2003) framework (Figure 1) provides a 
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foundation to understanding the variety of potential problems with recruitment; indeed, it 
is not until these factors are considered in relation to each other that a hierarchical model 
with capacity functioning as the dominant concept emerges. Although the other six forms 
of vulnerability are important to assess and monitor, capacity ultimately informs what 
impact those other factors have on an individual’s decision-making process. By better 
understanding how capacity functions within the research recruitment process, social 
workers would be better able to assess the impact and effect of the various other forms of 
vulnerability. 
Next Steps for Social Workers 
Social workers interested in research with vulnerable populations should first seek 
to become better informed and involved in all aspects of research. Fortunately, the 
interdisciplinary nature of social work practice and education provides those interested in 
accessing research with the necessary skillset to maneuver the complexities of biomedical 
research settings. A change in mindset to see research as an extension of practice as 
opposed to a completely separate field would be a good first step. Far too often in BSW 
and MSW education, it is implied that research and practice is a dichotomous choice. It 
might be helpful to begin teaching research as practice (and vice versa), which could 
partially increase the number of social workers involved in research. However, this 
educational change must occur from the top down; social work programs should provide 
more opportunities for social work students to interact professionally with other medical 
professions, statisticians, and bench scientists. In other words, students must be exposed 
to interdisciplinary collaboration as the norm from day one instead of being expected to 
navigate such collaboration merely upon entering the job market. Allowing students from 
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a wide set of disciplines to interact would help enhance the interdisciplinary approach 
that many health education programs are starting to enact. Furthermore, this change 
would provide students with a wider variety of research/practice outlets, thereby allowing 
them to naturally develop insights into how they might become more involved in health 
care research and practice settings.  
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IV. A Social Work Perspective on Vulnerability 
Introduction 
 Jane Addams wrote, “Action is indeed the sole medium of expression for ethics 
(1902, p. 273).” These words, written over 110 years ago, still ring true today, and are a 
mainstay within the field of social work ethics. This reflection largely concerns the 
vulnerable populations’ social workers encounter on a daily basis coupled with the field’s 
aim of making a difference in the community. However, it is not enough for social 
workers to consider the implications of action or inaction—both practitioners and 
researchers are part of a multi-generational reiterative process of implementing new and 
innovative ways of making the world a better place for oppressed and disenfranchised 
populations who find themselves broadly labeled as “vulnerable populations” (Frohlich & 
Potvin, 2008). Thus, the study of vulnerable populations is central to the efficacious 
practice and development of applicable social work theories for better advocating for, 
treating, and understanding those in the greatest need and considered at-risk (Aday, 1994; 
Gelberg et al., 2000). This intentional motivation highlights the ways in which social 
workers are uniquely positioned to understand the complex nature of vulnerability and 
the multidimensional ways in which it can manifest.  
Within social work practice, considerable time is spent discussing how to best 
work with different vulnerable populations, respect their self-determination, and navigate 
the complex systems necessary to advocate for clients. This advocating for vulnerable 
populations is a hallmark of the social work profession, and is one of the primary 
successes of the field. Although numerous methods are used in social work to address 
vulnerability in practice, the same attention has not been paid to research. For instance, 
the potential impacts of the utilization of the strengths perspective on the research 
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recruitment process have not been examined. Additionally, within the realm of research, 
a scant amount of data exist demonstrating how social workers are intervening within the 
research process to advocate for the rights of research participants, respect participants’ 
self-determination and autonomy, and do justice by looking at research participation as a 
right (Elks, 1993; John, 2007). 
The clinical practice of social work with pediatric and adolescent populations 
includes skills that are potentially of value in research with dually vulnerable populations. 
The professional and academic nature of social work is inherently interdisciplinary and 
addresses a diverse array of topics and vulnerable populations using a variety of 
philosophies and methods. As the social work profession continues to grow and diversify 
to address the needs of the ever-evolving social landscape, social workers are 
increasingly being tapped as direct members or consultants for interdisciplinary treatment 
and research teams (Maramaldi et al., 2014). Collaborative interdisciplinary care is 
becoming increasingly common in both acute and chronic care, as many cases must 
address a host of tangential issues connected to the illness, such as the mental health of 
the patient or the shifting family dynamics that illness can cause (Rothman & Wagner, 
2003). Collaborative interdisciplinary teams utilizing social workers have been 
particularly effective in the context of the medical model, and in addition to benefitting 
the patient, have provided social workers with a diversified view of healthcare and 
treatment (Bronstein, 2003). Academically, these collaborative teams allow social 
workers to participate in and have a direct impact on all facets of research and practice. 
Because social workers often provide counsel and advocacy for highly vulnerable 
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populations, they are in a unique position to fully understand and respond to a multitude 
of vulnerabilities both clinically and within a research setting. 
Pediatric and adolescent research is of vital importance for advancing our 
understanding of diseases and behaviors that affect young people, while recruitment of 
young participants is similarly vital for the advancement of human subjects research 
(Llewellyn-Thomas et al., 1991). Human subjects research is a highly multifaceted 
process with numerous different contributing variables at play in each stage. A key factor 
for social work practitioners and researchers to consider is: if we consider vulnerability a 
blanket term assigned to all minors, why do we believe that assent (gained after parental 
consent) is necessary? Accordingly, social workers may be poised to understand the 
complexity and nuance of vulnerability, and its use in research, including how and when 
it is applied as well as the protections that can be offered to alleviate it.  
The present review explores the concepts of “vulnerability” and “capacity” within 
research participation, with a specific focus on adolescents’ participation in research 
studies. A variety of factors influencing research participation are examined to deepen 
current understanding of the ways in which social work may enhance the ethical 
recruitment of subjects into research studies as well as increase inclusiveness, build 
stronger community relationships, and enhance the overall quality of research. As social 
work continues to build bridges between practice and research, it is crucial for such 
bridging to directly incorporate the values and traditions of the social work profession, by 
focusing on human relationships and human dignity, promoting responsible self-
determination, and challenging social injustice (National Association of Social Workers, 
2008). 
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Vulnerability and Capacity 
Capacity has been identified as the most important issue in pediatric research 
ethics (National Commission for the Protection of Human Subjects of Biomedical and 
Behavioral Research, 1977) as well as a critical issue in research with adolescents 
(Berman & Field, 2004). The issue of capacity is of specific concern in the recruiting and 
consenting process and represents a major barrier to recruitment of adolescent 
participants (Kipnis, 2003). Because ethical standards require an individual to be free of 
undue influence and coercion and limit use of unjustifiable pressure and manipulation, 
specific attention must be paid to how researchers interact with potential adolescent 
research participants (Department of Health, 1979). However, the inclusion of social 
workers and social work perspectives in pharmaceutical or clinical trial research may 
bring up issues that directly conflict with the NASW Code of Ethics. Within the Code of 
Ethics (2008), one section outlines that the social worker’s duty is to obtain informed 
consent that does not violate the terms and laws specified in both the Code and the 
Belmont Report (1979), where the concept of informed consent is thoroughly discussed.  
Closely related to the concept of capacity is “vulnerability.” Numerous definitions 
of “vulnerable populations” have been utilized that include criteria for how to know when 
a person/group is vulnerable (Hurst, 2008). The Declaration of Helsinki (1964) defined 
vulnerability as “…an increased likelihood of being wronged or of incurring additional 
harm.” Similarly, the National Bioethics Advisory Commission (2001) defined 
vulnerability according to participation: namely, those who are not fully capable of 
resisting the request to become participants (e.g., prisoners or institutionalized 
individuals) should not be enrolled in studies merely because they are easily accessible or 
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convenient. I adopted the following definition of vulnerability for this study: “The ability 
to give or withhold informed consent and the likelihood of being misled, mistreated, or 
otherwise taken advantage of in research” (Iltis, 2009) as it most concisely and directly 
relates to the concept of vulnerability in research settings.  
US federal regulations assign vulnerability as a blanket term to large groups of 
individuals without acknowledging their individual characteristics (C. Levine et al., 
2004). For instance, merely by not having attained the legal age to consent, anyone under 
the age of 18 years is considered vulnerable in the U.S., despite considerable evidence 
indicating that older adolescents have similar levels of capacity to make decisions as 
adults do (R. J. Levine, 1995; Partridge, 2013; Santelli et al., 1995). This propensity to 
ignore individual characteristics has led to both overuse and misuse of the term, thereby 
systematically eliminating potential participants according to group membership rather 
than actual vulnerability (C. Levine et al., 2004). This policy poses problems not only 
because it excludes potential participants from research, but also because it potentially 
masks people who require meaningful protection despite being legally eligible to 
participate. Given the biased and systematic exclusion resulting from this use of 
vulnerability, it is clear that a better understanding of capacity, or an individual’s ability 
to make informed decisions, is needed. Indeed, improving policies regarding capacity to 
consent can be considered a primary means of expanding the scope of adolescent clinical 
trial involvement and increasing the safety of health research. 
Discerning vulnerability can be even more complicated in pediatric research 
because of the circumstances surrounding the decision to participate in such research. 
When making decisions about adolescents’ research participation, a number of factors 
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must be evaluated. First, when recruiting minors, the research staff must recruit 
children’s parents and obtain their parental permission. The requirements for parental 
permission and assent in the context of human subjects research are outlined in the 
Department of Health and Human Services Code of Federal Regulations Title 45 Part 46 
and involve multiple disclosures to the subject and her/his parent, including the purpose 
and duration of the research, the procedures involved and if they are considered 
experimental, the risks, a contact for any questions, the fact that participation is entirely 
voluntary, and the fact that declining to participate will not render loss of other benefits 
or treatment (US Department of Health and Human Services, 2009). Second, the child 
must provide his or her assent, defined as “…a child's affirmative agreement to 
participate in research. Mere failure to object should not, absent affirmative agreement, 
be construed as assent” (US DHHS, Protection of Human Subjects, 2009, 46.402 subpart 
B). This need to acquire both consent and assent was implemented as a safeguard to 
ensure that both parents and children are properly informed and willing to participate in 
the research project.  
However, this requirement can cause problems when there is conflict between 
parent and child regarding participation or when parental permission is not a meaningful 
protection for the child (e.g., research on sensitive issues where parental involvement 
could prevent adolescent from participating or giving truthful responses). Current 
regulations award primary decision-making power to parents based solely on their 
children’s group-level vulnerability. There are, however, circumstances wherein minors 
are given the opportunity to provide consent without parental permission, including 
research on treatments or conditions in which the adolescent typically provides consent 
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for themselves, such as the diagnosis or treatment for sexually transmitted diseases 
(STDs), contraceptive services, prenatal care, substance abuse treatment, and mental 
health treatment (Boonstra & Nash, 2000; Guttmacher Institute, 2015). These minor 
consent laws vary by state; for example, screening and treatment for STDs is permissible 
in all 50 states without parental knowledge or permission, but only 34 states have explicit 
laws relating to consent for contraceptive services (Guttmacher Institute, 2015).  
These power differentials are important for social workers and other professionals 
that work with adolescents. For instance, depending on how adolescents and their parents 
are approached in the recruitment process, shared decision-making can be reduced when 
the social worker primarily engages the parent. Although generally accepted practice, this 
poses risks to adolescents’ emerging sense of autonomy, self-determination, and justice 
and can ultimately reduce their involvement in the decision making process. Furthermore, 
it may pose specific problems for clinicians and researchers in ethically and effectively 
interacting with adolescent participants. During mid to late adolescence, emphasis needs 
to be placed on supporting growing autonomy and responsibility. This concept is 
respected and given full weight when making treatment decisions, especially for sensitive 
topics (e.g., STD screening and treatment, pregnancy, mental health treatment, substance 
abuse treatment) (Hill, 2011). The explicit distinction between when parental consent is 
needed and when it can be waived is a sign that even within such a complex regulatory 
system it is unclear why and when every person under the age of 18 is considered 
vulnerable. Understanding this complex system and its impacts on clinical care and 
research recruitment can help social workers better navigate the systems as well as 
advocate for their adolescent clients.  
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A Framework for Understanding Vulnerability in Research with Adolescents 
As evidenced from above, vulnerability can be remarkably challenging to 
operationalize in related research. One approach would be designating every individual as 
having some form of vulnerability (Handmer, 2003) and therefore requiring tailored 
protection in certain situations. However, this might not be a reasonable definition 
because it is too cumbersome and time consuming to measure. Another approach is to 
identify specific vulnerable groups. However, this approach has the potential for 
stereotyping, thereby ultimately acting as a form of oppression term not adequately 
accounting for individual differences (C. Levine et al., 2004). A third alternative, which 
is perhaps the most suitable to date, is to examine the characteristics and situations that 
may lead to vulnerability for each specific study. Kipnis (2003) developed a framework 
of vulnerability to identify and categorize its differing manifestations in pediatric 
research participants. This framework gives researchers the ability to clarify what types 
of vulnerability might influence recruitment for their research projects. Kipnis suggests 
that vulnerability has seven main forms, as follows: (1) incapacitational, or an 
individual’s ability to make decisions using the information at hand (i.e., their capacity); 
(2) deferential, or when decisions are deferred to other professions or others in power; 
juridic, when someone has legal authority over an individual’s ability to make his or her 
own decisions; allocational, wherein factors such as education and poverty may impact 
an individual’s decision; medical, which refers to how an individual feels obligated to 
participate due to a health condition for which there are few or unsatisfactory cures; 
situational, or when someone has an illness that prevents them from engaging in the 
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necessary deliberation for an informed decision to participate; and social, or being a 
member of group with a history of being socially devalued (Kipnis, 2003). 
It is important to note that at any one point in time, any number of these types of 
vulnerability could affect an individual and may be highly dependent on the situation. For 
this reason, it is crucial that social workers more closely examine how vulnerability is 
formulated, evaluated, and addressed. In assessing vulnerability, capacity, and informed 
consent, social workers have a unique training and perspective that could allow them to 
play a useful role in protecting research participants (Kipnis, 2003). The most important 
form of vulnerability for social workers to consider in making determinations about 
informed consent is arguably incapacitational vulnerability. For adolescents, providing 
informed consent relies mainly on the idea of a capacity to make that decision, which is 
an aspect of decision making for research participation unique to adolescents. For this 
reason, a social work perspective of the seven types of vulnerability should seek to 
conceptualize incapacitational vulnerability, or capacity, as the overarching variable from 
which all other forms of vulnerability manifest. 
Illustrating the Types of Vulnerability in Practice 
As noted in the previous section, multiple types of vulnerability may be at play at 
one time and simple group membership should not be an identifying factor. Social 
workers can play a role by identifying the type of vulnerability and take a strengths based 
perspective in supporting that vulnerability. Starting with the overarching concept, 
attempting to gain greater insight into adolescent capacity would provide social workers 
in a research setting with a better idea of how well the potential research participant 
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understands the information being presented and how he/she has integrated that new 
knowledge into the existing frameworks of understanding that he/she already possesses.  
In a research setting, adolescents who lack capacity may not be able to tell 
research staff what the risks and benefits of their participation are. Specifically, they 
might be unable to recall or understand what is expected of them if they choose to 
participate in the study; beyond this, they might be unaware that they have a choice to 
participate or be unable to make that choice based on the information provided. In these 
circumstances, it is ethically justifiable to exclude these adolescents from the study on the 
basis that they do not have adequate understanding of the relevant information needed to 
participate. Conversely, this may be the opportunity to provide enhanced information on 
the study procedures and help the potential participant to come to a decision. Deciding 
whether to eliminate or provide further information requires careful balance between 
overprotectiveness and coercion. It would help to identify specific procedures for such 
situations early on in protocol development.  
After decisions have been made about whether an adolescent has capacity, 
additional steps can be taken to identify other types of vulnerability that might affect the 
potential participant’s experience in the research setting. Adolescents with deferential and 
juridic vulnerability may feel compelled to participate based on relationships and 
perceived expectations from the research staff, parents, doctors, etc. Addressing these 
two types of vulnerability would require finding ways to reduce or eliminate the 
perceived pressure on the potential participant to help him/her feel as though he/she has a 
voice in the decision making process. Such methods of reducing deferential and juridic 
vulnerability might include common language explanations that let adolescents know that 
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no one expects anything of them; that it is completely their decision on if they want to 
participate; and that if they decide that they do not want to participate or change their 
mind about participating in the future, it is completely permissible and will have no 
impact on their relationship with the medical team, research staff, etc. The most 
important issue to be aware of with such types of vulnerability is that due to their status 
as minors, their parents’ presence, and the perceived power differential inherent between 
research staff and participants, adolescents will always feel a baseline level of 
compulsory participation. Social workers are ideally positioned to screen for deferential 
behavior that shows misalignment between the preferences of the adolescent and what is 
expected of them. Throughout the informed consent process, social workers skills in 
building a rapport with the potential participant can help better assess for the presence of 
deferential or juridic vulnerability.  
Concerns of coercion are common in all types of human subject research(Largent, 
Grady, Miller, & Wertheimer, 2012; Oakes, 2002), and this fear is compounded when 
considering adolescent participation in research (Brody & Waldron, 2000). Kipnis’s 
(2003) framework allows for social work researchers to examine the issues of perceived 
power differentials and possible financial inducement more deeply, to truly consider the 
division of benefits received as well as the fairness of the situation as a whole. Issues of 
allocational vulnerability go far deeper than remuneration for research participation, and 
defining, identifying, and correcting this type of vulnerability provides one of the greatest 
challenges to researchers looking to design ethically defensible research protocols with 
adolescents. However, it is this difficultly that plays into social work’s natural strength to 
quickly assess and remedy issues with power imbalance, resource allocation, justice, and 
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fairness. Within the realm of allocational vulnerability, concerns over payments 
functioning as an inducement should be considered; however, a broader focus on the just 
recruitment of adolescent subjects should consider access to research, fair compensation 
for time and expertise, and ensuring that the target group of study is characteristically 
similar to the group that would benefit from the research. Ways of controlling for this 
type of vulnerability include conscious research design as well as enhanced interactions 
between research staff, parents, and adolescent participants.  
The medical and situational types of vulnerability are of concern in adolescent 
research because they present a potential lack of time and available options to make an 
informed decision (Kipnis, 2003). This is particularly true with adolescent cancer 
diagnoses, where the only option for treatment might be a therapeutic trial that needs to 
begin immediately on diagnosis. In this case, both the medical and situational conditions 
may cause adolescent and their parents to feel forced into a decision because of such a 
lack of time or options. However, this exigency coupled with the overwhelming nature of 
such a sudden or traumatic situation fits well into medical social work’s natural role as 
communication facilitators and enhancers. When medical and situational vulnerabilities 
are of concern, social workers are a necessary force to ensure that all parties are given as 
much helpful information as possible in a caring and empathic manner. It is social work’s 
specific focus on the role of the individual within a large series of connected systems that 
can help to alleviate these tensions. 
Summary of vulnerability 
Capacity emerges as a key concept in understanding and contextualizing the 
different forms vulnerability. Utilizing Kipnis’s (2003) framework (Figure 1) provides a 
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foundation to understanding the variety of potential problems with recruitment; indeed, it 
is not until these factors are considered in relation to each other that a hierarchical model 
with capacity functioning as the dominant concept emerges. Although the other six forms 
of vulnerability are important to assess and monitor, capacity ultimately informs what 
impact those other factors have on an individual’s decision-making process. By better 
understanding how capacity functions within the research recruitment process, social 
workers would be better able to assess the impact and effect of the various other forms of 
vulnerability. 
 
Figure 1. Conceptualization of Kipnis’s (2003) vulnerability framework and 
requirements for consent. 
Next Steps for Social Workers 
Social workers interested in research with vulnerable populations should first seek 
to become better informed and involved in all aspects of research. Fortunately, the 
interdisciplinary nature of social work practice and education provides those interested in 
accessing research with the necessary skillset to maneuver the complexities of biomedical 
research settings. A change in mindset to see research as an extension of practice as 
opposed to a completely separate field would be a good first step. Far too often in BSW 
and MSW education, it is implied that research and practice is a dichotomous choice. It 
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might be helpful to begin teaching research as practice (and vice versa), which could 
partially increase the number of social workers involved in research. However, this 
educational change must occur from the top down; social work programs should provide 
more opportunities for social work students to interact professionally with other medical 
professions, statisticians, and bench scientists. In other words, students must be exposed 
to interdisciplinary collaboration as the norm from day one instead of being expected to 
navigate such collaboration merely upon entering the job market. Allowing students from 
a wide set of disciplines to interact would help enhance the interdisciplinary approach 
that many health education programs are starting to enact. Furthermore, this change 
would provide students with a wider variety of research/practice outlets, thereby allowing 
them to naturally develop insights into how they might become more involved in health 
care research and practice settings.  
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V. Banking the future: Adolescent capacity to consent to biobank research 
Introduction 
Pediatric biobanks are important to understanding the long-term consequences of 
pediatric disease as well as discovering methods to prevent adult diseases during 
childhood. Additional reasons for looking more closely at adolescent consent in 
biobanking research are direct results of the nature of indefinitely storing samples from 
minors that will age into adults. This simple reality highlights an overarching need for 
adolescents to be directly involved in the consent process from the very beginning of 
enrollment. Beyond this, there is a direct need to support developing autonomy in minors 
that shows a respect for them as individual’s who can have a direct say in their 
participation in research. Biobanking includes the long-term storage of samples from 
individuals with linkages between the biological sample and personal health information. 
Samples in these facilities can include any type of biological material: blood, feces, urine, 
cell cultures, saliva, etc. (Spriggs & Fry, 2015)  
The main difference between biobanking studies and general clinical research is 
the collection and indefinite storage of biological information linked to various aspects of 
an individuals personal health record as opposed to an individual agreeing to provide 
information and or samples for a clearly defined research purpose. In biobanking there is 
no defined research question the subject is agreeing to participate in, they are instead 
agreeing to provide a sample that can be utilized for any purpose. This difference in 
intent and purpose of sample collection poses specific challenges for consent for all 
potential participants, minor or not. This challenge is compounded when considering 
developmental trajectories as well as samples can be collected from minors and then 
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finally used in a research study after they have reached the age majority. While this idea 
of consent is considered a risk in biobanking studies it should also be noted that the 
potential for benefit could be high. This paper will discuss ways in which we may be able 
to go about reconciling concerns about consent with adolescent participation in 
biobanking research in hopes of tipping the scale of risk/benefit to show that the potential 
gains in collecting adolescent and pediatric samples (personalized medicine, better 
understanding the life-course of adult diseases, and potential use of genetic material in 
cures for diseases to name a few) far outweigh the risks associated with sample 
collection.  
Similarly to adult biobanking studies, consent is of great concern in pediatric 
biobanking. Current assent procedures do not take into account pediatric capacity to 
provide consent and does not take into account the developmental differences between 
younger pediatric populations and older adolescents. Self-consent from older pediatric 
populations may be important in showing respect for growing autonomy as well as 
allowing adolescents’ to have a direct say in the long-term banking of their biological 
material as well as linkages with personal health information. For instance, while a 15 
year old may understand why they are giving a biobank a sample of their blood, they will 
have no way of knowing what happens to their blood and how the information is used 
later on down the line. Specifically of concern in pediatric biobanking is how samples are 
utilized over time and the evolving nature of capacity to provide informed consent.  
Ethical concerns around voluntariness and the consent process have been 
described for adult biobanks (Anderson & DuBois, 2012; Brothers & Clayton, 2009). 
These concerns are even more important in pediatric populations due to the evolving 
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nature of capacity and the longitudinal banking of samples collected while the donor was 
a minor and potentially being used after they have reached the age of majority. This also 
brings up concerns about how/when/if participants should be contacted when their 
samples are used in different study types (Brothers & Clayton, 2009). 
Due to the majority of issues with pediatric biobanking centering on the consent 
process it is important to first evaluate the components that make up informed consent. 
Capacity to consent is a concept that generally refers to an individual’s ability to make an 
informed decision about participation in research or treatment (Clausen, 1991; Weithorn 
& Campbell, 1982). In this research, the idea of capacity will be operationalized through 
four criteria that can be thought to influence an individual’s capacity to give or withhold 
consent. The criteria for capacity are based on Applebaum & Roth’s (1982) framework 
and include 1) utilizing understanding of the information relevant to make a decision, 2) 
appreciation of the significance of the decision (e.g., that the decision truly is one’s own), 
3) the ability to manipulate the information rationally and engage in reasoning, and 4) the 
ability to communicate the intended decision by making a choice. 
While adult research has validated a number of tools for individuals with 
dementia and severe mental illness to capture waning capacity, there are no adolescent 
specific tools to capture evolving capacity. For this reason, developing adolescent and 
pediatric capacity assessment tools that seek to systematically assess capacity are of 
fundamental importance to ensuring research ethics. Development and successful 
implementation of such tools will provide researchers with contextualized information on 
participants’ capacity to consent relative to the specific study they are attempting to 
enroll in. This study adapted the MacCAT-CR for use with adolescents’ because of the 
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emerging data to support the success of the MacCAT-CR with a wide variety of adults. 
Additionally, the MacCAT-CR provides much more information to researchers and 
clinicians compared to other capacity assessments, which do not cover all four functional 
areas thought to be necessary to provide a valid informed consent.  
Methods 
Study instruments 
MacCAT-CR. The MacArthur Competence Assessment Tool for Clinical 
Research (MacCAT-CR) is a comprehensive assessment tool for adult capacity 
assessments (Appelbaum & Grisso, 2001). There are emerging data supporting its use 
with adolescents (Hein et al., 2012; Hein et al., 2014; Koelch, Prestel, Singer, Schulze, & 
Fegert, 2010). The effectiveness of the tool stems from its focus on the four criteria 
thought to be required for consent: factual understanding of the issues, appreciation of the 
nature of the situation, rational manipulation of information, and evidence of choice 
(Appelbaum & Roth, 1982; Kim, 2010; Turrell, Peterson-Badali, & Katzman, 2011). Use 
of the MacCAT-CR with chronically ill adults has been shown to be a reliable and 
effective way to assess patient capacity for clinical trials (Karlawish, Casarett, & James, 
2002). This project sought to evaluate the effectiveness of the MacCAT-CR on a mixed 
sample of healthy and chronically ill children and adolescents. Effectiveness with 
chronically ill participants was important to assess as these are the pediatric populations 
most likely to participate in clinical trials research (Koelch et al., 2009). The MacCAT-
CR was developed for use in participants with waning capacity, but emerging data has 
applied the tool to child populations to evaluate emerging capacity (Karlawish, 2008; 
Kim & Caine, 2002; Palmer et al., 2005). This presents a unique opportunity for those 
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wishing to start biobanking with adolescent populations as (to date) no adolescent 
specific biobanking studies have been done. 
The tool utilizes semi-structured, open-ended questions to assess a potential 
participants ability to comprehend study specific information based on the four criteria 
thought to be necessary for consent. Each question is scored on a 0-2 scale where 0 
indicates that the respondent did not correctly answer any portion of the question, 1 
indicating that they were able to identify some portion of the correct answer, and 2 
indicating that they were able to provide a response that captured all ideal aspects of a 
response. Since each version of the MacCAT-CR needs to be study specific in order to 
assess capacity, multiple individuals with topic expertise were consulted in developing 
the scoring rubric. 
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Figure 2. MacCAT-CR items 
Specifically when assessing adolescent capacity to consent we were interested in 
how social/behavioral factors played into an adolescents ability to consent, and if there 
was a difference in those relationships between healthy and chronically ill participants. 
There is emerging information on the association between health literacy, family 
affluence, and age on capacity, and we we’re interested to see how these factors would 
impact capacity assessment scores on the two different adolescent populations. 
REALM. Health literacy has been identified as one of the most important 
emerging constructs in health care communication (Dumenci, Matsuyama, Kuhn, Perera, 
& Siminoff, 2013), and is currently viewed as a key factor in determinates of health care 
utilization and outcomes (Sentell, Baker, Onaka, & Braun, 2011). The REALM is one of 
Comprehensive breakdown of the modified MacCAT-CR
Understanding
Appreciation
Reasoning
Expressing a choice
What makes you want to consider participating in this study?
How might [risk or benefit] affect your daily life?
Do you believe this study is primarily for research or primarily for treatment?
Now that we've discussed everything, do you think you want to participate?
What will happen if a person refuses to be in the research project?
 If you withdraw from this study, will you still be able to receive regular treatment?
Do you believe that you have been asked to be in this study primarily for your personal benefit?
What makes you believe that this was/wasn’t the reason you were asked?
What do you believe would happen if you were to decide not to be in this study?
What makes you believe that this would happen?
Is it possible that being in this study will not have any benefit to you?
In what way might people who volunteer be better off by being in this research project?
What might doctors learn about diseases if people decide to be in this research project?
What unpleasant side effects might people experience in this study?
What uncomfortable things are done to people in the study?
Who will pay for your medical care if you are injured as a direct result of participating in this study?
How long will the research project last?
What is the purpose of the research project I described to you?
What sorts of things will people have to do if they agree to be in the study?
What sorts of things will be done with people who agree to be in the study?
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the highest utilized assessments to assess health literacy (Berkman, Sheridan, Donahue, 
Halpern, & Crotty, 2011).The REALM consists of 66-items and is currently the most 
utilized test of health literacy in research settings (Dumenci et al., 2013). The 66-items 
administered take less than 5-minutes to administer and produce a raw score than can be 
quickly converted into five different reading grade equivalencies. The REALM is 
administered by having participants read down a list of common medical terms, when a 
word is pronounced correctly the participant receives one point. If a word is not 
attempted, mispronounced, or altered in anyway the participant does not receive a point 
for that word. The test relies heavily on an individual’s ability to read and sound out 
words that range from common to higher complexity medical terminology. An example 
of words on the REALM are: fat, flu, pill, colitis, osteoporosis, jaundice, anemia, and 
constipation. 
FASII. The family affluence scale II is a self-reported measure that has been 
validated for use in adolescents and is considered to be a more accurate measure of 
adolescents perceptions of SES than traditional self-report measures (Boudreau & Poulin, 
2009; Boyce, Torsheim, Currie, & Zambon, 2006; Currie, Elton, Todd, & Platt, 1997; 
Currie et al., 2008). Traditional SES scales administered to adults were found to be 
inaccurate when utilized with adolescents due to differences in adolescents’ perceptions 
of SES and their parents’ true status. Development of the FASII attempted to identify 
related questions that would be easy to know and articulate while also corresponding 
directly to actual SES of the larger family unit. The FASII is a quickly administered tool 
that focuses on objective statues that exist within households; does the respondent have 
their own bedroom, how many cars does the family have, how many vacations a year 
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does the family go on, and how many computers does the family own. These four items 
form a scale that ranges from 0-9 with 0-2 corresponding with low affluence, 3-5 with 
middle affluence, and 6-9 indicating high affluence when compared to the global 
population (Boyce et al., 2006). 
Chronic illness 
Because adolescents with chronic illness may differ from healthy adolescents in 
ways relevant to capacity to consent (e.g., different developmental course, experience 
with clinical procedures), it is necessary to separately assess their capacity and evaluate it 
in comparison to otherwise healthy participants. Due to concerns of coercion and other 
types of medical, situational, and developmental vulnerabilities thought to be present in 
pediatric and adolescent research (Kipnis, 2003), we sought to examine the impact of 
chronic illness on potential research participants capacity to consent to research 
participation. Chronic illness in this study was measured using three self-report items that 
asked participants’ if they (1) had a chronic illness, (2) if they took daily medicine, and 
(3) if they had ever spent the night in the hospital. Questions of chronic illness and 
experience with the medical system served as an easy way to evaluate relationships 
between the lived experiences of adolescents and what (if any) impact this has on 
decision making.  
Participants 
This study included adolescent aged children from ages 12-24. Primary inclusion 
criteria were age and ability to read and speak English. Exclusion criteria included 
individuals who were obviously intoxicated, high, or altered as well as individuals 
obviously lacking the capacity to understand study procedures due to severe medical 
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illness or significant cognitive impairment, as assessed by the parent, if the participants 
were minors, or the interviewer based upon the participants’ ability to understand and 
give informed consent for the study. This study included a broad community-based 
recruitment strategy pulling in adolescents from universities and community clinics. The 
institutional review board approved the research protocol, adolescents provided consent, 
and parents/guardians provided permission for those under 18 years of age.  
Recruitment 
The study sample is comprised of a broad sample of individuals recruited 
primarily in adolescent health clinics and throughout the community. Multiple methods 
of recruitment were used, including clinic recruitment, convenience sampling, and 
snowball sampling, This approach allowed us to recruit adolescents across a range of 
socio-demographic characteristics and life experiences. This recruitment approach was 
employed to be similar to those used for clinical and behavioral research with healthy 
adolescents. 
Procedures 
A structured instrument collected information on demographic, developmental, 
medical history and health literacy from participants. Interviews were conducted in a 
private location of the participant’s choosing, and participants were reminded that they 
could refuse to answer any question for any reason. Then the interviewer went through 
three separate informed consent processes for different types of clinical studies that were 
presented as if the participant were planning on participating in each study. After each 
informed consent process, the interviewer administered study-specific measures of 
capacity to consent. Participants were given a $20 gift card for their participation. 
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Statistical analysis 
Statistical analyses were performed with SPSS version 23. Demographic 
characteristics and initial bivariate analyses of main study measures were compared 
utilizing correlation. A receiver Operating Characteristic (ROC) curve was produced to 
evaluate the performance of the MacCAT-CR as a binary classifier of capacity or no 
capacity based on variables found to be significantly related in bivariate analysis. Use of 
the ROC curve was a deliberate attempt to use a mathematical approach in developing an 
objective cutoff score for ease of use in clinical settings. In this analysis, the scores of the 
MacCAT-CR were dichotomized based on numerical threshold value arrived at through 
content experts evaluations of the various dimensions. Regression analysis was utilized to 
evaluate predictors that impact overall MacCAT-CR score. Criterion and convergent 
validity were evaluated to assess how well the MacCAT-CR was able to measure 
capacity in the sample through comparison to clinical interviews. Group consensus was 
utilized to ensure homogeneity amongst scores across all items where each interview was 
coded twice, when differences in raters scoring of items occurred the group listened to 
the transcript together to determine a consensus score.  
Results 
Participants 
We enrolled and interviewed 78 adolescents’ ages 12-24 (Mean=17.00, SD=2.84) 
who were mostly female (62.5%) in a 70-90 minute scored semi-structured interview. For 
the overall sample, participants had a mean score of 61 on the Rapid Estimate of Adult 
Learning in Medicine (REALM), or approximately 8th-9th grade reading level, which 
represents a similar or higher than average score than reported adult scores (Davis et al., 
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1994; Kaphingst, Ali, Taylor, & Kass, 2010). When looking at participants’ 
socioeconomic status the mean score was 6.53 (SD=1.79) corresponding to upper middle 
class, with a wide amount of distribution of scores across all possible values of the scale. 
23.6% of the sample responded as having some type of chronic illness, as well as 31.9% 
reporting that they had stayed overnight in the hospital due to being sick, and 44.4% 
reporting taking daily medicine other than vitamins or supplements.  
 
Table 1. Summary of outcome variables 
Capacity to consent 
For the MacCAT-CR the overall raw score across the sample was 30.6 (SD=4.7) 
out of a total of 36 possible points. This value reflects that within our sample overall 
decision-making capacity was high. When looking at the sub-scores of the MacCAT-CR 
based on the four different components of capacity, participants had a mean score of 16.4 
(SD=3.0) on the understanding section of a possible 20 points, 5.3 (SD=1.1) on the 
appreciation section with a highest possible score of 6, and 6.8 (SD=1.5) on the reasoning 
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section of a possible 8 points. One hundred percent answered affirmatively to the 
question, “Do you have a choice to participate in the study?”  
Age, health literacy and family affluence 
Correlation analysis also supported a relationship between FAS, age, and REALM 
scores and the different dimensions of the MacCAT-CR, which were all positively 
correlated. The one exception was for FAS score and the understanding portion of the 
MacCAT-CR, which approached statistical significance.  
We also wanted to examine the MacCAT-CR not only as a tool that could give 
researchers a better insight into potential participants’ capacity, but also as an objective 
tool to discern capacity. For this we relied on individuals with expertise in capacity to 
determine a cutoff scoring value that would force a dichotomy of “has capacity” and 
“lacks capacity.” Utilizing concurrent criterion validity as well as construct validity we 
developed a receiver operating characteristic (ROC) curve to help illustrate how the 
predictor variables found to have significant correlations helped predict whether an 
individual would have capacity or not. Values for FAS and age were classified as “fair” 
tests for separating individuals into the dichotomous capacity outcome, and helped to 
arrive at a score of 28 for differentiating between those who have capacity and those who 
are lacking capacity. The score of the REALM emerged as a “good” test for correctly 
classifying adolescents’ level of capacity. Overall this test indicates that the modified 
MacCAT-CR is sensitive and specific enough to adequately classify individual levels of 
capacity.  
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Graph 1. ROC curve results 
 
Based on our results from correlation analysis we utilized SPSS to do a stepwise 
linear regression. The second model consisted of REALM and FAS scores as predictive 
variables and had an R2 of 56.4%, other predictor variables were removed as they failed 
to reach the level of significance required. Beta values for both variables were .68 for the 
REALM and .263 for FAS. Age was removed from the final model as it failed to remain 
significant in the presence of the FAS and REALM scores. 
 
Age:     .54-.83; p<.05 
FAS:     .59-.86; p<.01 
REALM:.70-.94; p<.001 
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Table 2. Linear regression results 
Interpretation 
Adolescent capacity to consent to biobanks was similar to scores similar range as 
normal adults in similar studies using the MacCAT-CR (Appelbaum & Grisso, 2001; 
Hein et al., 2012; McDermott, Gerbasi, Quanbeck, & Scott, 2005), and most strongly 
associated with family affluence and health literacy. This contrasts with the current 
federal regulations, which use only age as their criteria for providing consent, and 
provides insights into ways to ethically involve minors in consent for biobanking and 
similar research. This initial finding is suggests that using standardized measures of 
family affluence and health literacy may provide greater insights on capacity.  
Chronic illness was not found to be a significant factor in capacity to consent and 
went against our initial hypothesis that the differing level of exposure to health care 
settings and familiarity with health care professionals would positively impact 
adolescents’ ability to provide consent. However, this may have been an issue of power 
due to only having 23.6% of the sample of 78 having a chronic illness. Future studies 
should focus on recruiting higher numbers of chronically ill and healthy participants as 
well as more participants with a greater severity of chronic illness. Our sample consisted 
mainly of participants’ with asthma and diabetes, two diagnoses with a range of severity 
and illness experiences.  
Multiple Linear Regression for MacCAT-CR Biobanking Scores
Predictor Variable   B (SE) β t
REALM .57 (.07) 0.68** 7.81
FAS .70 (.23)  0.26*  3.02
R2 0.56
F 37.45
* p<.01 . **p<.001.
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Conclusion 
The benefits of adolescent and pediatric biobanking far outweigh the potential 
risks associated with informed consent, potential losses of confidentiality, and concerns 
centered on the longitudinal nature of pediatric biobanking. Specific benefits include the 
ability to gain information about diseases specifically related to adolescent populations, 
safer inclusion of adolescents in research protocols, and showing respect for emerging 
adolescent autonomy. Although the potential benefits may outweigh the potential risks, 
research protocols including informed consenting processes need to be systematically 
developed so that the potential participant’s ability to provide informed consent can be 
effectively assessed. Our efforts to find a minimally acceptable level of capacity to 
consent for adolescents provided insights for future consideration including the need to 
develop study specific measures of capacity, deeper insight into the interactions between 
the four criteria considered necessary for capacity are needed, and developing a cutoff 
score for capacity determinations may be more complicated than a simple additive 
formula.  
For those lacking capacity, enhanced informed consenting processes should 
provide adequate protections and education. Tough decisions need to be made when 
considering adolescent participation especially with individuals who lack capacity to 
provide informed consent. Should research be closed off to these individuals? Or is the 
research team obligated to provide additional information and education to these 
individuals in a way that will functionally raise their level of capacity to consent? 
Although formalized assessment of an adolescent’s is only the first step in this process, 
this information should benefit researchers by better understanding the participants who 
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come into their studies as well as quelling anxieties centered on vulnerable population 
research participation. 
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VI. Conclusion 
 The field of social work is built upon the idea and spirit of making a difference, 
changing things for the better, and giving voice to those who otherwise may not have an 
outlet to share their experience. Far too often in this field we force artificial divisions or 
choices upon our students and practitioners; research, clinical, or practice. I have heard 
these three categories mentioned before in countless conversations amongst students at 
all levels of education, and I could not possibly disagree more with the presentation that 
these are mutually exclusive categories. As I have come to understand social work, 
thankfully through a great amount of exposure to other countries views on what social 
work is and does (thanks mostly to the Korean cohort in my program), I take personal 
issue with limiting a field so expansive, so interdisciplinary by design, and so focused on 
achieving outcomes that transcend the very categories ascribed to it. This project 
represents a culmination of those ideas put into practice.  
 The first article presented was a review of a bioethical framework for 
understanding pediatric and adolescent vulnerability in research. This article was the 
basis for developing the second article that focused on testing adolescent capacity to 
consent to research. To understand the different types of vulnerability one might 
experience in research settings it is important to have a multidimensional understanding 
of the ways in which researchers and others in the medical professions have come to 
understand capacity. The two concepts are fundamentally linked in a reflexive and 
constantly evolving state responsive to a wide variety of interpersonal and environmental 
factors. Whereas the first article walked through the different types of vulnerabilities and 
ways social work could act to identify/reduce their impact on individuals, the second 
79 
 
article focused on evaluating the ways in which perceived vulnerabilities impacted 
individuals enrolling in a more complex biobanking study. In this study the data showed 
that family affluence (a measure of socioeconomic status) and adolescents’ level of health 
literacy were two of the most important factors in whether or not an adolescent would 
have capacity to consent. This finding begins to call into question the age-based criterion 
currently utilized in research participation regulations. This is of importance to illustrate 
that our current age-based definitions of child and adult may be a forced artificial 
dichotomy that is not representative of the ideas and values our research regulations and 
ethical codes are seeking to establish.  
 Both the conceptual and data-driven articles reflect the current social climate—
across numerous domains we are seeking to give voice to individuals who have 
previously been excluded. In a time where we are seeking to develop and embrace more 
inclusive categories that better explain individual characteristics is not time to revisit our 
reliance on age as a criteria for decision-making? The work presented hopefully (at the 
very least) begins to call into question the foundation upon which those policies are built.  
 Shifting to think of capacity as a moving target is of special importance for those 
interested in research ethics, particularly research with populations identified as 
vulnerable, at risk, or hard to reach. Developing new ways to enroll individuals in a way 
that provides greater privacy, respect for diverse opinions, enhanced value to the 
individual, and opportunities to share unique experiences is by far my greatest interest 
when considering my future research trajectory. I have been very fortunate to get 
opportunities to work in spaces that are truly interested in making research more 
reflective and helpful to the populations they involve. My dissertation project was 
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graciously funded through a competitive grant from the Clinical and Translational 
Sciences Institute that focuses on conducting scientific research in a way that makes the 
results applicable and understandable to the population being studied. A key component 
to this type of research is interdisciplinary communication and collaboration, which are 
components I hope to integrate into my future research. Interdisciplinary work is a 
hallmark of social work and one that has helped me move from interdisciplinary 
understanding of issues to transdisciplinary.  
Using a wide lens perspective to evaluate methodological issues in the research 
process for vulnerable and stigmatized populations is my greatest interest. Luckily for 
me, this interest easily integrates into a wide variety of fields and types of research and 
would not have been possible without my exposure to medicine, psychology, sociology, 
public health, and education research methods. This dissertation process has provided me 
with the opportunity to learn how to navigate complex and overlapping systems to design 
and implement translational research directly focused on enhancing the overall research 
experience for a wider variety of research participants.  
My future research will focus heavily on the methods we use to examine hidden 
and hard to reach populations. This feels like the next most logical extension of my work 
and interests, and I will seek to illuminate new ways to reach and effectively study highly 
vulnerable populations. My post-doctoral position will allow me to do just that. While I 
have worked solely with adolescents for the past five years, my next role will give me an 
opportunity to expand what I have learned to other vulnerable populations. 
 
 Appendix A—Measures 
Children with Special Health Care Needs (CSHCN) Screener 
1. Do you currently need or use medicine prescribed by a doctor (other than vitamins)? 
Yes   Go to Question 1a 
No    Go to Question 2 
 1a. Is this because of ANY medical, behavioral or other health problem? 
  Yes   Go to Question 1b 
  No    Go to Question 2 
   1b. Is this a problem that has lasted or is expected to last for at least 1 
year? 
    Yes   
     No    
2. Do you get extra help in school, work with a therapist or counselor, or spend more time at the 
doctor’s office than other kids your age? 
Yes   Go to Question 2a 
No    Go to Question 3 
 2a. Is this because of ANY medical, behavioral or other health problem? 
  Yes   Go to Question 2b 
  No    Go to Question 3 
   2b. Is this a condition that has lasted or is expected to last for at least 1 
year? 
    Yes   
    No    
3. Are you limited or prevented in any way in your ability to do the things other kids your age 
can do? 
Yes   Go to Question 3a 
No    Go to Question 4 
 3a. Is this because of ANY medical, behavioral or other health problem? 
  Yes   Go to Question 3b 
  No   Go to Question 4 
   3b. Is this a condition that has lasted or is expected to last for at least 1 
year? 
    Yes   
    No    
4. Do you need or get any kind of special therapy, such as physical, occupational or speech 
therapy? 
Yes   Go to Question 4a 
No    Go to Question 5 
 4a. Is this because of ANY medical, behavioral or other health problem? 
  Yes   Go to Question 4b 
  No   Go to Question 5 
   4b. Is this a condition that has lasted or is expected to last for at least 1 
year? 
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    Yes   
    No   
5. While in school or at home, do you often get into trouble, have a hard time keeping your grades 
up, or feel unhappy or depressed for which you need or get medicine or counseling? 
Yes  Go to Question 5a 
No     
 5a. Has this problem lasted or is it expected to last for at least 12 months? 
    Yes   
    No    
 
Have you ever been told that you have any of the following conditions? 
____ Anemia      
____ Bleeding 
____ gynecological-menstrual problems  
____ PCOS/Hormonal problems  
____ Back problems     
____ Rheumatologic problem/arthritis 
____ Musculoskeletal problems  
____ Headaches/Migraines  
  
____ Chronic fatigue    
____ Chronic pain    
____ Diabetes      
____ Cancer/tumor   
  
____ Bowel/Stomach problems  
____ Epilepsy or seizures    
____ Eye problems  
____ Hearing problems    
____ Fever      
____ Asthma     
____ Heart problems 
____ Kidney/Bladder trouble  
____ Lung disease 
____ Liver disease/hepatitis 
____ Skin disorders 
____ Substance abuse 
____ Anxiety 
____ Depression 
____ ADHD 
  
____ Any other type of disease/condition not 
listed:________________________________________________ 
Note to interviewer—clarify any condition above, if minor, then (-) 
 
For any of the above conditions, what treatment do/did you need (medicine, therapy, etc.)?  
______________________________________________________________________________
_______________ 
How much did the above condition impact your daily functioning? (list scale of 1-5 for each 
condition—1 being not at all—5 being prevented from engaging in school, family, play, etc. list 
number next to condition) 
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PHQ-9 
Over the last 2 weeks, how often have you been bothered by any of the following problems? 
(Please circle a number to indicate your answer) 
 
 
  
 
PHQ-9  Not at all 
Several 
days 
More 
than half 
the days 
Nearly 
everyday 
1. Little Interest or pleasure in doing 
things 0 1 2 3 
2. Feeling down, depressed, or hopeless 0 1 2 3 
3. trouble falling or staying asleep, or 
sleeping too much 0 1 2 3 
4. Feeling tired or having little energy 0 1 2 3 
5. Poor appetite or overeating 0 1 2 3 
6. Feeling bad about yourself—or that 
you are a failure or have let yourself 
down 
0 1 2 3 
7. Trouble concentrating on things, such 
as reading or watching TV 0 1 2 3 
8. Moving or speaking so slowly that 
other people could have noticed. Or the 
opposite—being so fidgety or restless 
that you have been moving around a lot 
more than usual 
0 1 2 3 
9. Thoughts that you would be better off 
dead, or of hurting yourself 0 1 2 3 
For Office Use     
 
10. If you checked off any problems, how 
difficult have these problems made it for 
you to do your work, take care of things 
at homes, or get along with other people? 
Not 
difficult at 
all 
Somewhat 
difficult 
Very 
difficult 
Extremely 
difficult 
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Demographics 
Please put an “X” in the box to select your answer. 
Correct:    Incorrect: ! 
(12-13 year olds) 
 
1. Age: _________ years 
 
2. Ethnicity: 
  White 
  African American 
  Latino 
  Asian or Pacific Islander 
  Other 
 
3. Gender 
  Male 
  Female 
  Transgender or other 
 
4. Grade 
  6th 
  7th 
  8th 
  9th 
  10th 
  11th 
  12th 
  Graduated High School 
  Received a GED 
  Not in school but haven’t graduated or 
received GED 
  College or technical training 
  College Degree (Bachelor’s, Associate’s) 
 
5. Have you ever had to stay overnight in the hospital because you were sick? 
  Yes   No 
  
6. Do you have any chronic illnesses (diabetes, asthma, cancer, etc.)? 
  Yes   No 
 
7. Do you take any daily medicines (other than vitamins or supplements)? 
  Yes   No 
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8. During the past 30 days, on how many days did you smoke cigarettes? 
  0 days  
  1 or 2 days  
  3 to 5 days  
  6 to 9 days  
  10 to 19 days  
  20 to 29 days  
  All 30 days
 
9. During the past 30 days, what is the largest number of alcoholic drinks you had in a row, 
that is, within a couple of hours? 
  I did not drink alcohol during the 
past 30 days 
  1 or 2 drinks 
  3 drinks 
  4 drinks 
  5 drinks 
  6 or 7 drinks 
  8 or 9 drinks 
  10 or more drinks 
 
10. During the past 30 days, how many times did you use marijuana? 
  0 times 
  1 or 2 times 
  3 to 9 times 
  10 to 19 times 
  20 to 39 times 
  40 or more times 
 
11. Skip 
 
12. Skip 
 
13. During the past 12 months, how many times did someone you were dating or going out 
with physically hurt you on purpose? (Count such things as being hit, slammed into 
something, or injured with an object or weapon.) 
  I did not date or go out with 
anyone during the past 12 
months 
  0 times  
  1 time 
  2 or 3 times 
  4 or 5 times 
  6 or more times 
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14. During the past 7 days, how many times did you eat fruit? (Do not count fruit juice.) 
  I did not eat fruit during the past 7 days 
  1 to 3 times during the past 7 days 
  4 to 6 times during the past 7 days 
  1 time per day 
  2 times per day 
  3 times per day 
  4 or more times per day 
15. On an average school night, how many hours of sleep do you get? 
  4 or less hours 
  5 hours 
  6 hours 
  7 hours 
               8 hours 
               9 hours 
               10 or more hoursDoes your family own a car, van, or truck? 
  Yes, one 
  Yes, two or more 
  No
 
16. Do you have a bedroom for yourself? 
  Yes   No
 
17. During the past 12 months, how many times did you travel away on holiday with your 
family? 
  Not at all 
  Once 
               Twice 
               More than two 
 
18. How many computers does your 
family own? 
  None 
  One 
  Two 
  More than two  
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REALM 
Instructions: 
1.  Examiner should say to the subject: 
“This survey is to help us figure out the best type of patient education materials 
for you. The survey only takes 2 to 3 minutes to do.” 
2. Give the subject a laminated copy of the “REALM” Patient Word List. 
3. Examiner should hold an unlaminated “REALM” Score Sheet on a clipboard at an angle 
so that the subject is not distracted by the scoring procedure. 
4. Examiner should say: 
“I want to hear you read as many words as you can from this list. Begin with the 
first word on List 1 and read aloud. When you come to a word you cannot read, 
do the best you can or say “blank” and go on to the next word.” 
5. If the subject takes more than five seconds on a word, say “blank” and point to the next 
work, if necessary, to move the subject along. If the subject begins to miss every word, 
have him/her pronounce only known words. 
6. Count as an error any word not attempted or mispronounced. 
7. Count the number of correct words for each list. Total the numbers. 
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List 1 List 2 List 3 
Fat Fatigue Allergic 
Flu Pelvic Menstrual 
Pill Jaundice Testicle 
Dose Infection Colitis 
Eye Exercise Emergency 
Stress Behavior Medication 
Smear Prescription Occupation 
Nerves Notify Sexually 
Germs Gallbladder Alcoholism 
Meals Calories Irritation 
Disease Depression Constipation 
Cancer Miscarriage Gonorrhea 
Caffeine Pregnancy Inflammatory 
Attack Arthritis Diabetes 
Kidney Nutrition Hepatitis 
Hormones Menopause Antibiotics 
Herpes Appendix Diagnosis 
Seizure Abnormal Potassium 
Bowel Syphilis Anemia 
Asthma Hemorrhoids Obesity 
Rectal Nausea Osteoporosis 
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Incest Directed Impetigo 
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Semi-structured MacCAT-CR Interview Guide 
Pharmaceutical consent: 
A migraine headache is a type of headache that may come with symptoms like feeling sick to 
your stomach, throwing up, or sensitivity to lights. For this consent, I’d like you to imagine that 
you have migraine headaches, and your doctor has told you about this research project for a 
migraine medicine. 
Take a few minutes and read this consent form. Afterwards, we will go over it and I will ask you 
some questions to check your understanding. 
Understanding 
The purpose of this study is to test the safety of MigrainaGon and how well it works in 
adolescents and young adults. This study will last for 12 weeks. Subjects will have an initial 
study visit where they will have a physical exam and a blood draw. They will take the first dose 
of medicine in the clinic. When they go home, they will take the medicine when they have a 
headache and write down how much pain they feel after 30 minutes, 1 hour, and 2 hours. 
Do you have any questions about what we read? 
a) What is the purpose of the research project I described to you? 
b) How long will the research project last? 
c) What sorts of things will be done with people who agree to be in the study? 
d) What sorts of things will people have to do if they agree to be in the study? 
It is important for you to understand that the project in which you have been asked to participate 
in a research project. That means its main purpose is to help the doctors figure out whether the 
new medication can help some people with migraine headaches. The main purpose is not to find 
out whether it works for people in the study, as it would be if this were ordinary treatment. 
Do you have any questions? 
e) Do you believe this study is primarily for research or primarily for treatment? 
Because this is a research project, not ordinary treatment, the doctors will be doing things that 
they would not do in ordinary hospitals/clinics, like those where you may have been treated 
before. For example, some people who are in this project will get the new medication, but others 
will get a sugar pill instead – a pill with no medicine in it (called a placebo). Whether they get the 
new medication of the sugar pill will be decided by chance. The doctors will know if the subject 
is getting the new medication or the placebo. The subjects will not know. All these things are 
done to see whether the new medication is better than no medication at all. 
Do you have any questions? 
f) Will all people in the project get the study medication? 
g) How will it be determined what kind of pills each of the people in the project receive? 
h) Who will know what kind of pill each person in the study is taking? 
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There are a few benefits of participating in this study. Doctors will learn more about how this 
migraine medicine works in young adults and people under the age of 18. You may have pain 
relief while taking the drug, but that is not guaranteed. 
Do you have any questions? 
i) What might doctors learn about the treatment of migraines if people decide to be in this 
research project? 
j) In what way might people who volunteer be better off by being in this research project? 
a. Is it possible that being in this study will not have any benefit to you? 
There are also risks associated with participating in this study. Subjects experienced physical side 
effects, like tingling sensation, weakness, nausea, and dizziness. Some people might have a life-
threatening reaction called serotonin syndrome if they are taking anti-depressant medicine at the 
same time. 
Subjects will also have their blood drawn at the initial visit. 
Do you have any questions? 
k) What unpleasant side effects can the medication cause in some people? 
l) What uncomfortable things are done to people in the study? 
No one has to be in this study. People who agree to be in this research can change their minds at 
any time. If they don’t agree to be in this study or if they decide to stop, they will be referred to 
their doctor for the usual treatment for migraines. 
m) What will happen if a person refuses to be in the research project, or decides to stop once 
they have started? 
a. If you withdraw from this study, will you still be able to receive regular 
treatment? 
Appreciation  
n) Do you believe that you have been asked to be in this study primarily for your personal 
benefit? 
a. What makes you believe that this was/wasn’t the reason you were asked? 
o) Do you believe you could get the sugar pill? 
a. What makes you believe this could/couldn’t happen to you? 
p) What do you believe would happen if you were to decide not to be in this study? 
a. What makes you believe that this would happen? 
Expressing a Choice  
As you know, you have been invited to participate in a research project testing a medication for 
the treatment of migraine headaches. Do you think you are more likely to want to participate or 
more likely to not want to participate? 
You think that you are more likely to want to/not want to participate. Tell me what it is that 
makes that option better than the other option. 
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q) What makes you want to consider participating in this study? 
We’ve talked about some of the risks of the study, like [mention risks they said], and some of the 
benefits, like [mention risks they said]. What are some ways that these could affect your everyday 
activities if you participate in the research project? 
r) How might [risk or benefit] affect your daily life? 
A few moments ago you told me that you were/were not likely to want to participate in the 
research project. What do you think know that we have discussed everything?
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Biobank consent: 
For this consent, I’d like you to imagine that you are at the doctor’s office for a routine visit. 
Your doctor approaches you with a research study called “The Indiana Biobank” and asks if you 
would be interested in participating. 
The purpose of this study is to collect a biological sample, like blood, from healthy and sick 
people to use in future research. We will collect a small amount of blood from a vein in your arm. 
This sample will be stored indefinitely in our facility. We will also collect personal health 
information from you, like your date of birth, race, and medical record number. 
a) What is the purpose of the research project I described to you? 
b) How long will the research project last? 
c) What sorts of things will be done with people who agree to be in the study? 
d) What sorts of things will people have to do if they agree to be in the study? 
It is important for you to understand that this project is a research project. That means its main 
purpose is to help the doctors collect biological samples for future research. 
e) Do you believe this study is primarily for research or primarily for treatment? 
There are no direct benefits to you for participating in the study. The primary benefit is to learn 
information from your sample about illnesses (like cancer or diabetes) that can help with 
preventing or treating these illnesses in the future. 
f) What might doctors learn about diseases if people decide to be in this research project? 
g) In what way might people who volunteer be better off by being in this research project? 
a. Is it possible that being in this study will not have any benefit to you? 
There are some risks involved with participating in this research study. You may experience pain 
or bruising when they draw blood from your arm. There is a risk of loss of confidentiality, which 
means someone can identify you and see your results. Your DNA is unique to you, and if other 
people see this information, it could affect your ability to have a certain job or get health 
insurance in the future. 
h) What unpleasant side effects might people experience in this study? 
i) What uncomfortable things are done to people in the study? 
j) Who will pay for your medical care if you are injured as a direct result of participating in 
this study? 
No one has to be in this study. People who agree to be in this research project can change their 
minds at any time. If they don’t agree to be in this study or if they decide to stop, they will 
receive their normal care in their doctor’s office or hospital. 
k) What will happen if a person refuses to be in the research project? 
a. If you withdraw from this study, will you still be able to receive regular 
treatment? 
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Appreciation 
l) Do you believe that you have been asked to be in this study primarily for your personal 
benefit? 
a. What makes you believe that this was/wasn’t the reason you were asked? 
m) What do you believe would happen if you were to decide not to be in this study? 
b. What makes you believe that this would happen? 
Expressing a Choice 
As you know, you have been invited to participate in a research project for banking a biological 
sample, in this case blood. Do you think you are more likely to want to participate or more likely 
to not want to participate? 
You think that you are more likely to want to/not want to participate. Tell me what it is that 
makes that option better than the other option. 
n) What makes you want to consider participating in this study? 
We’ve talked about some of the risks of the study, like [mention risks they said], and some of the 
benefits, like [mention risks they said]. What are some ways that these could affect your everyday 
activities if you participate in the research project? 
o) How might [risk or benefit] affect your daily life? 
 A few moments ago you told me that you were/were not likely to want to participate in the 
research project. What do you think know that we have discussed everything? 
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STD consent: 
For this consent, I’d like you to imagine that you are a teenager who has been approached (after 
school, at the skating rink, basketball court?) to participate in a research project about STDs in 
Indianapolis youth. 
The purpose of this study is to look at how common certain STDs are in the Indianapolis area. 
We will collect urine samples from approximately 1200 young people and test for gonorrhea, 
chlamydia, and trichomonas. Once the testing is done, we will call participants and tell them their 
results. 
a) What is the purpose of the research project I described to you? 
b) How long will the research project last? 
c) What sorts of things will be done with people who agree to be in the study? 
d) What sorts of things will people have to do if they agree to be in the study? 
It is important for you to understand that the project in which you have been asked to participate 
in a research project. That means its main purpose is to look at how many people have STDs. The 
main purpose is not treat STDs, as it would be if this were ordinary treatment. 
e) Do you believe this study is primarily for research or primarily for screening and 
treatment? 
There are some benefits to you for participating in this study. The primary benefit is that you will 
get a free STD test. If you test positive for an STD, we can help you get treatment. That can mean 
sending you to a doctor or writing you a prescription for antibiotics. 
f) What might doctors learn about STDs if people decide to be in this research project? 
g) In what way might people who volunteer be better off by being in this research project? 
a. Is it possible that being in this study will not have any benefit to you? 
There are some risks involved with participating in this research study. You may feel 
uncomfortable with some of the questions we ask you. There is a risk of loss of confidentiality, 
which means someone can identify you and see your STD test results. 
h) What uncomfortable thing do people in the study have to do? 
i) What can happen in a case of loss of confidentiality? 
No one has to be in this study. People who agree to be in this research project can change their 
minds at any time, and they can stop at any time. 
j) What will happen if a person refuses to be in the research project, or decides to stop once 
they have started? 
a. If you withdraw from this study, will you still be able to receive regular 
treatment? 
Appreciation  
k) Do you believe that you have been asked to be in this study primarily for your personal 
benefit? 
a. What makes you believe that this was/wasn’t the reason you were asked? 
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l) What do you believe would happen if you were to decide not to be in this study? 
a. What makes you believe that this would happen? 
Expressing a Choice 
As you know, you have been invited to participate in a research project testing Indianapolis youth 
for STDs and asking them questions about their sexual behavior. Do you think you are more 
likely to want to participate or more likely to not want to participate? 
You think that you are more likely to want to/not want to participate. Tell me what it is that 
makes that option better than the other option. 
m) What makes you want to consider participating in this study? 
We’ve talked about some of the risks of the study, like [mention risks they said], and some of the 
benefits, like [mention risks they said]. What are some ways that these could affect your everyday 
activities if you participate in the research project? 
n) How might [risk or benefit] affect your daily life? 
A few moments ago you told me that you were/were not likely to want to participate in the 
research project. What do you think now that we have discussed everything?
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MacCAT-CR Interview Cards (to be read by subject) 
Pharmaceutical consent: 
The purpose of this study is to test the safety of MigrainaGon and how well it works in 
adolescents and young adults. This study will last for 12 weeks. Subjects will have an initial 
study visit where they will have a physical exam and a blood draw. They will take the first dose 
of medicine in the clinic. When they go home, they will take the medicine when they have a 
headache and write down how much pain they feel after 30 minutes, 1 hour, and 2 hours. 
It is important for you to understand that the project in which you have been asked to participate 
in a research project. That means its main purpose is to help the doctors figure out whether the 
new medication can help some people with migraine headaches. The main purpose is not to find 
out whether it works for people in the study, as it would be if this were ordinary treatment. 
Because this is a research project, not ordinary treatment, the doctors will be doing things that 
they would not do in ordinary hospitals/clinics, like those where you may have been treated 
before. For example, some people who are in this project will get the new medication, but others 
will get a sugar pill instead – a pill with no medicine in it (called a placebo). Whether they get the 
new medication of the sugar pill will be decided by chance. The doctors will know if the subject 
is getting the new medication or the placebo. The subjects will not know. All these things are 
done to see whether the new medication is better than no medication at all. 
There are a few benefits of participating in this study. Doctors will learn more about how this 
migraine medicine works in young adults and people under the age of 18. You may have pain 
relief while taking the drug, but that is not guaranteed. 
There are also risks associated with participating in this study. Subjects experienced physical side 
effects, like tingling sensation, weakness, nausea, and dizziness. Some people might have a life-
threatening reaction called serotonin syndrome if they are taking anti-depressant medicine at the 
same time. 
Subjects will also have their blood drawn at the initial visit. 
No one has to be in this study. People who agree to be in this research can change their minds at 
any time. If they don’t agree to be in this study or if they decide to stop, they will be referred to 
their doctor for the usual treatment for migraines. 
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Biobank consent: 
The purpose of this study is to collect a biological sample, like blood, from healthy and sick 
people to use in future research. We will collect a small amount of blood from a vein in your arm. 
This sample will be stored indefinitely in our facility. We will also collect personal health 
information from you, like your date of birth, race, and medical record number. 
It is important for you to understand that this project is a research project. That means its main 
purpose is to help the doctors collect biological samples for future research. 
There are no direct benefits to you for participating in the study. The primary benefit is to learn 
information from your sample about illnesses (like cancer or diabetes) that can help with 
preventing or treating these illnesses in the future. 
There are some risks involved with participating in this research study. You may experience pain 
or bruising when they draw blood from your arm. There is a risk of loss of confidentiality, which 
means someone can identify you and see your results. Your DNA is unique to you, and if other 
people see this information, it could affect your ability to have a certain job or get health 
insurance in the future. 
No one has to be in this study. People who agree to be in this research project can change their 
minds at any time. If they don’t agree to be in this study or if they decide to stop, they will 
receive their normal care in their doctor’s office or hospital. 
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STD consent: 
The purpose of this study is to look at how common certain STDs are in the Indianapolis area. 
We will collect urine samples from approximately 1200 young people and test for gonorrhea, 
chlamydia, and trichomonas. Once the testing is done, we will call participants and tell them their 
results. 
It is important for you to understand that the project in which you have been asked to participate 
in a research project. That means its main purpose is to look at how many people have STDs. The 
main purpose is not treat STDs, as it would be if this were ordinary treatment. 
There are some benefits to you for participating in this study. The primary benefit is that you will 
get a free STD test. If you test positive for an STD, we can help you get treatment. That can mean 
sending you to a doctor or writing you a prescription for antibiotics. 
There are some risks involved with participating in this research study. You may feel 
uncomfortable with some of the questions we ask you. There is a risk of loss of confidentiality, 
which means someone can identify you and see your STD test results. 
No one has to be in this study. People who agree to be in this research project can change their 
minds at any time, and they can stop at any tim 
 
  
  
100 
References 
Aday, L. A. (1994). Health status of vulnerable populations. Annual Review of Public 
Health, 15(1), 487–509. doi:10.1146/annurev.pu.15.050194.002415 
Addams, J. (1902). Democracy and social ethics. New York: Macmillan. 
Anderson, E. E., & DuBois, J. M. (2012). IRB decision-making with imperfect 
knowledge: A framework for evidence-based research ethics review. Journal of 
Law, Medicine & Ethics, 40(4), 951–969. doi:10.1111/j.1748-720X.2012.00724.x 
Appelbaum, P. S., & Grisso, T. (2001). MacArthur competence assessment tool for 
clinical research (MacCAT-CR). Sarasota, FL: Professional Resource 
Press/Professional Resource Exchange. 
Appelbaum, P. S., Lidz, C. W., & Meisel, A. (1987). Informed consent: Legal theory and 
clinical practice.  
Appelbaum, P. S., & Roth, L. H. (1982). Competency to consent to research: A 
psychiatric overview. Archives of General Psychiatry, 39(8), 951–958. 
doi:10.1001/archpsyc.1982.04290080061009 
Beresford, B. A., & Sloper, P. (2003). Chronically ill adolescents’ experiences of 
communicating with doctors: A qualitative study. Journal of Adolescent Health, 
33(3), 172–179. doi:10.1016/S1054-139X(03)00047-8 
Berkman, N. D., Sheridan, S. L., Donahue, K. E., Halpern, D. J., & Crotty, K. (2011). 
Low health literacy and health outcomes: An updated systematic review. Annals 
of Internal Medicine, 155(2), 97–107. doi:10.7326/0003-4819-155-2-201107190-
00005 
  
101 
Berman, R. E., & Field, M. J. (2004). The ethical conduct of clinical research involving 
children. Washington, DC: National Academies Press. 
Boonstra, H., & Nash, E. (2000). Minors and the right to consent to health care. The 
Guttmacher Report on Public Policy, 3(4), 4–8.  
Boudreau, B., & Poulin, C. (2009). An examination of the validity of the Family 
Affluence Scale II (FAS II) in a general adolescent population of Canada. Social 
Indicators Research, 94(1), 29–42. doi:10.1007/s11205-008-9334-4 
Boyce, W., Torsheim, T., Currie, C., & Zambon, A. (2006). The Family Affluence Scale 
as a measure of national wealth: Validation of an adolescent self-report measure. 
Social Indicators Research, 78(3), 473–487. doi:10.1007/s11205-005-1607-6 
Brody, J. L., Annett, R. D., Scherer, D. G., Perryman, M. L., & Cofrin, K. M. (2005). 
Comparisons of adolescent and parent willingness to participate in minimal and 
above-minimal risk pediatric asthma research protocols. Journal of Adolescent 
Health, 37(3), 229–235. doi:10.1016/j.jadohealth.2004.09.026 
Brody, J. L., Turner, C. W., Annett, R. D., Scherer, D. G., & Dalen, J. (2012). Predicting 
adolescent asthma research participation decisions from a structural equations 
model of protocol factors. Journal of Adolescent Health, 51(3), 252–258. 
doi:10.1016/j.jadohealth.2011.12.015 
Brody, J. L., & Waldron, H. B. (2000). Ethical issues in research on the treatment of 
adolescent substance abuse disorders. Addictive Behaviors, 25(2), 217–228. 
doi:10.1016/S0306-4603(99)00041-6 
Bronstein, L. R. (2003). A model for interdisciplinary collaboration. Social Work, 48(3), 
297–306. doi:10.1093/sw/48.3.297 
  
102 
Broome, M. E. (1999). Consent (assent) for research with pediatric patients. Seminars in 
Oncology Nursing, 15(2), 96–103. doi:10.1016/S0749-2081(99)80067-9 
Broome, M. E., Richards, D. J., & Hall, J. M. (2001). Children in research: The 
experience of ill children and adolescents. Journal of Family Nursing, 7(1), 32–
49. doi:10.1177/107484070100700103 
Brothers, K. B., & Clayton, E. W. (2009). Biobanks: Too long to wait for consent. 
Science, 326(5954), 798. doi:10.1126/science.326_798a 
Clausen, J. S. (1991). Adolescent competence and the shaping of the life course. 
American Journal of Sociology, 96(4), 805–842. doi:10.1086/229609 
Condon, J. (1986). The ‘unresearched’-those who decline to participate. Australian and 
New Zealand Journal of Psychiatry, 20(1), 87–89. 
doi:10.3109/00048678609158870 
Conroy, H., & Harcourt, D. (2009). Informed agreement to participate: Beginning the 
partnership with children in research. Early Child Development and Care, 179(2), 
157–165. doi:10.1080/03004430802666973 
Corbie-Smith, G., Thomas, S. B., Williams, M. V., & Moody-Ayers, S. (1999). Attitudes 
and beliefs of African Americans toward participation in medical research. 
Journal of General Internal Medicine, 14(9), 537–546. doi:10.1046/j.1525-
1497.1999.07048.x 
Currie, C., Elton, R., Todd, J., & Platt, S. (1997). Indicators of socioeconomic status for 
adolescents: The WHO Health Behaviour in School-aged Children Survey. Health 
Education Research, 12(3), 385–397. doi:10.1093/her/12.3.385 
  
103 
Currie, C., Molcho, M., Boyce, W., Holstein, B., Torsheim, T., & Richter, M. (2008). 
Researching health inequalities in adolescents: The development of the Health 
Behaviour in School-Aged Children (HBSC) family affluence scale. Social 
Science & Medicine, 66(6), 1429–1436. doi:10.1016/j.socscimed.2007.11.024 
Davis, T. C., Mayeaux, E. J., Fredrickson, D., Bocchini, J. A. Jr., Jackson, R. H., & 
Murphy, P. W. (1994). Reading ability of parents compared with reading level of 
pediatric patient education materials. Pediatrics, 93(3), 460–468. 
Dempsey, J. P., Back, S. E., Waldrop, A. E., Jenkins, L., & Brady, K. T. (2008). The 
influence of monetary compensation on relapse among addicted participants: 
Empirical vs. anecdotal evidence. American Journal on Addictions, 17(6), 488–
490. doi:10.1080/10550490802408423 
Department of Health, E., and Welfare,. (1979). The Belmont report: Ethical principles 
and guidelines for the protection of human subjects of research. Washington, DC:  
Dumenci, L., Matsuyama, R. K., Kuhn, L., Perera, R. A., & Siminoff, L. A. (2013). On 
the validity of the Rapid Estimate of Adult Literacy in Medicine (REALM) scale 
as a measure of health literacy. Communication Methods and Measures, 7(2), 
134–143. doi:10.1080/19312458.2013.789839 
Elks, M. L. (1993). The right to participate in research studies. The Journal of Laboratory 
and Clinical Medicine, 122(2), 130–136. 
Emanuel, E. J. (2005). Undue inducement: Nonsense on stilts? The American Journal of 
Bioethics, 5(5), 9–13. doi:10.1080/15265160500244959 
  
104 
Emanuel, E. J., & Miller, F. G. (2007). Money and distorted ethical judgments about 
research: Ethical assessment of the TeGenero TGN1412 trial. The American 
Journal of Bioethics, 7(2), 76–81. doi:10.1080/15265160601111800 
Epstein, R. A. (2007). Conflicts of interest in health care: Who guards the guardians? 
Perspectives in Biology & Medicine, 50(1), 72–88. doi:10.1353/pbm.2007.0002 
Faden, R. R., Beauchamp, T. L., & King, N. M. (1986). A history and theory of informed 
consent.  
Fernandez, C. V., Santor, D., Weijer, C., Strahlendorf, C., Moghrabi, A., Pentz, R., . . . 
Kodish, E. (2007). The return of research results to participants: Pilot 
questionnaire of adolescents and parents of children with cancer. Pediatric Blood 
& Cancer, 48(4), 441–446. doi:10.1002/pbc.20766 
Fisher, C. B., Hoagwood, K., Boyce, C., Duster, T., Frank, D. A., Grisso, T., . . . Zayas, 
L. H. (2002). Research ethics for mental health science involving ethnic minority 
children and youths. American Psychologist, 57(12), 1024–1040. 
doi:10.1037/0003-066X.57.12.1024 
Fisher, C. B., Wallace, S. A., & Fenton, R. E. (2000). Discrimination distress during 
adolescence. Journal of Youth and Adolescence, 29(6), 679–695. 
doi:10.1023/A:1026455906512 
Fisher, J. A., & Kalbaugh, C. A. (2011). Challenging assumptions about minority 
participation in US clinical research. American Journal of Public Health, 101(12), 
2217–2222. doi:10.2105/AJPH.2011.300279 
  
105 
Fisher, J. A., & Kalbaugh, C. A. (2012). United States private-sector physicians and 
pharmaceutical contract research: A qualitative study. PLoS Medicine, 9(7), 
e1001271. doi:10.1371/journal.pmed.1001271 
Frohlich, K. L., & Potvin, L. (2008). Transcending the known in public health practice: 
The inequality paradox: The population approach and vulnerable populations. 
American Journal of Public Health, 98(2), 216–221. 
doi:10.2105/AJPH.2007.114777 
Gelberg, L., Andersen, R. M., & Leake, B. D. (2000). The Behavioral Model for 
Vulnerable Populations: Application to medical care use and outcomes for 
homeless people. Health Services Research, 34(6), 1273–1302.  
Grady, C. (2001). Money for research participation: Does it jeopardize informed consent? 
American Journal of Bioethics, 1(2), 40–44. doi:10.1162/152651601300169031 
Grant, R. W., & Sugarman, J. (2004). Ethics in human subjects research: Do incentives 
matter? Journal of Medicine and Philosophy, 29(6), 717–738. 
doi:10.1080/03605310490883046 
Guttmacher Institute. (2015). An overview of Minors’ Consent Law. New York, NY: 
Guttmacher Institute. Retrieved from 
http://www.guttmacher.org/statecenter/spibs/spib_OMCL.pdf 
Handmer, J. (2003). We are all vulnerable. Centre for Risk and Community Safety. 
RMIT University.  
Hein, I. M., Troost, P. W., Lindeboom, R., Benninga, M. A., Zwaan, C. M., van 
Goudoever, J. B., & Lindauer, R. J. (2014). Accuracy of the MacArthur 
competence assessment tool for clinical research (MacCAT-CR) for measuring 
  
106 
children’s competence to consent to clinical research. JAMA Pediatrics, 168(12), 
1147–1153. doi:10.1001/jamapediatrics.2014.1694 
Hein, I. M., Troost, P. W., Lindeboom, R., de Vries, M. C., Zwaan, M. C., & Lindauer, 
R. J. L. (2012). Assessing children’s competence to consent in research by a 
standardized tool: A validity study. BMC Pediatrics, 12, 156. doi:10.1186/1471-
2431-12-156 
Hill, B. J. (2011). Whose body? Whose soul? Medical decision-making on behalf of 
children and the free exercise clause before and after Employment Division v. 
Smith. Cardozo Law Review, 32, 1857.  
Holden, G., Rosenberg, G., Barker, K., Tuhrim, S., & Brenner, B. (1993). The 
recruitment of research participants. Social Work in Health Care, 19(2), 1–44. 
doi:10.1300/J010v19n02_01 
Hurst, S. A. (2008). Vulnerability in research and health care; describing the elephant in 
the room? Bioethics, 22(4), 191–202. doi:10.1111/j.1467-8519.2008.00631.x 
John, J. E. (2007). The child’s right to participate in research: Myth or misconception? 
British Journal of Nursing, 16(3), 157–160. doi:10.12968/bjon.2007.16.3.22969 
Kaphingst, K. A., Ali, J., Taylor, H. A., & Kass, N. E. (2010). Rapid estimate of adult 
literacy in medicine: Feasible by telephone? Family Medicine, 42(7), 467–468.  
Karlawish, J. H. (2008). Measuring decision-making capacity in cognitively impaired 
individuals. Neurosignals, 16(1), 91–98. doi:10.1159/000109763 
Karlawish, J. H., Casarett, D. J., & James, B. D. (2002). Alzheimer’s disease patients’ 
and caregivers’ capacity, competency, and reasons to enroll in an early-phase 
  
107 
alzheimer’s disease clinical trial. Journal of the American Geriatrics Society, 
50(12), 2019–2024. doi:10.1046/j.1532-5415.2002.50615.x 
Katon, W. J. (2011). Epidemiology and treatment of depression in patients with chronic 
medical illness. Dialogues in Clinical Neuroscience, 13(1), 7–23.  
Kim, S. Y. (2010). Evaluation of capacity to consent to treatment and research. New 
York, NY: Oxford University Press. 
Kim, S. Y., & Caine, E. D. (2002). Utility and limits of the mini mental state examination 
in evaluating consent capacity in Alzheimer’s disease. Psychiatric Services. 
53(10), 1322–1324. doi:10.1176/appi.ps.53.10.1322 
Kipnis, K. (2003). Seven vulnerabilities in the pediatric research subject. Theoretical 
Medicine and Bioethics, 24(2), 107–120. doi:10.1023/a:1024646912928 
Klitzman, R. (2013). How IRBs view and make decisions about coercion and undue 
influence. Journal of Medical Ethics, 39(4), 224–229. doi:10.1136/medethics-
2011-100439 
Koelch, M., Prestel, A., Singer, H., Schulze, U., & Fegert, J. M. (2010). Report of an 
initial pilot study on the feasibility of using the MacArthur competence 
assessment tool for clinical research in children and adolescents with attention-
deficit/hyperactivity disorder. Journal Of Child And Adolescent 
Psychopharmacology, 20(1), 63–67. doi:10.1089/cap.2008.0114 
Koelch, M., Singer, H., Prestel, A., Burkert, J., Schulze, U., & Fegert, J. M. (2009). 
"...because I am something special" or "I think I will be something like a guinea 
pig": Information and assent of legal minors in clinical trials--assessment of 
  
108 
understanding, appreciation and reasoning. Child and Adolescent Psychiatry and 
Mental Health, 3(1), 2. doi:10.1186/1753-2000-3-2 
Kuhlthau, K., Hill, K., Yucel, R., & Perrin, J. (2005). Financial burden for families of 
children with special health care needs. Maternal and Child Health Journal, 9(2), 
207–218. doi:10.1007/s10995-005-4870-x 
Kumpunen, S., Shipway, L., Taylor, R. M., Aldiss, S., & Gibson, F. (2012). Practical 
approaches to seeking assent from children. Nurse Researcher, 19(2), 23–27. 
doi:10.7748/nr2012.01.19.2.23.c8905 
Lally, M., Goldsworthy, R., Sarr, M., Kahn, J., Brown, L., Peralta, L., & Zimet, G. 
(2014). Evaluation of an intervention among adolescents to reduce preventive 
misconception in HIV vaccine clinical trials. Journal of Adolescent Health, 55(2), 
254–259. doi:10.1016/j.jadohealth.2014.01.006 
Largent, E. A., Grady, C., Miller, F. G., & Wertheimer, A. (2012). Money, coercion, and 
undue inducement: A survey of attitudes about payments to research participants. 
IRB: Ethics & Human Research, 34(1), 1–8.  
Lerner, R. M., & Steinberg, L. (2004). The scientific study of adolescent development. 
Handbook of adolescent psychology.  
Levine, C., Faden, R., Grady, C., Hammerschmidt, D., Eckenwiler, L., & Sugarman, J. 
(2004). The limitations of “vulnerability” as a protection for human research 
participants. The American Journal of Bioethics, 4(3), 44–49. 
doi:10.1080/15265160490497083 
  
109 
Levine, R. J. (1995). Adolescents as research subjects without permission of their parents 
or guardians: Ethical considerations. Journal of Adolescent Health, 17(5), 287–
297. doi:10.1016/1054-139X(95)00175-R 
Llewellyn-Thomas, H. A., McGreal, M. J., Thiel, E. C., Fine, S., & Erlichman, C. (1991). 
Patients’ willingness to enter clinical trials: Measuring the association with 
perceived benefit and preference for decision participation. Social Science & 
Medicine, 32(1), 35–42. doi:10.1016/0277-9536(91)90124-u 
London, A. J., Borasky, D. A. Jr., Bhan, A., & Ethics Working Group of the HIV 
Prevention Trials Network. (2012). Improving ethical review of research 
involving incentives for health promotion. PLoS Medicine, 9(3), e1001193. 
doi:10.1371/journal.pmed.1001193 
Macklin, R. (1989). The paradoxical case of payment as benefit to research subjects. IRB: 
Ethics & Human Research, 11(6), 1–3. doi:10.2307/3564182 
Maramaldi, P., Sobran, A., Scheck, L., Cusato, N., Lee, I., White, E., & Cadet, T. J. 
(2014). Interdisciplinary medical social work: A working taxonomy. Social Work 
in Health Care, 53(6), 532–551. doi:10.1080/00981389.2014.905817 
McDermott, B. E., Gerbasi, J. B., Quanbeck, C., & Scott, C. L. (2005). Capacity of 
forensic patients to consent to research: The use of the MacCAT-CR. The Journal 
of the American Academy of Psychiatry and the Law, 33(3), 299–307. 
McGregor, K. A., Ott, M. A., Lally, M., & Zimet, G. (2014). Predictors of adolescent 
decision making regarding HIV vaccine trial participation. Paper presented at the 
Society for Social Work and Research 18th Annual Conference: Research for 
Social Change: Addressing Local and Global Challenges. San Antonio, Texas. 
  
110 
McLoyd, V. C. (1998). Changing demographics in the American population: Implications 
for research on minority children and adolescents. In V. C. McLoyd & L. 
Steinberg (Eds.), Studying minority adolescents: Conceptual, methodological, and 
theoretical issues (pp. 3–28). Mahwah, N.J.: Lawrence Erlbaum Associates.  
Miller, F. G., & Wertheimer, A. (2007). Facing up to paternalism in research ethics. 
Hastings Center Report, 37(3), 24–34. doi:10.1353/hcr.2007.0044 
Morris, M. C. (2012). Pediatric participation in non-therapeutic research. Journal of Law, 
Medicine & Ethics, 40(3), 665–672. doi:10.1111/j.1748-720X.2012.00697.x 
National Bioethics Advisory Commission. (2001). Ethical and policy issues in research 
involving human participants. Bethesda, MD: National Bioethics Advisory 
Commission. 
National Commission for the Protection of Human Subjects of Biomedical and 
Behavioral Research. (1977). Report and recommendations: Research involving 
children. Bethesda, Maryland: DHEW publication. 
Oakes, J. M. (2002). Risks and wrongs in social science research: An evaluator’s guide to 
the IRB. Evaluation Review, 26(5), 443–479. doi:10.1177/019384102236520 
Palmer, B. W., Dunn, L. B., Appelbaum, P. S., Mudaliar, S., Thal, L., Henry, R., . . . 
Jeste, D. V. (2005). Assessment of capacity to consent to research among older 
persons with schizophrenia, Alzheimer disease, or diabetes mellitus: Comparison 
of a 3-item questionnaire with a comprehensive standardized capacity instrument. 
Archives of General Psychiatry, 62(7), 726–733. doi:10.1001/archpsyc.62.7.726 
  
111 
Partridge, B. C. (2013). The decisional capacity of the adolescent: An introduction to a 
critical reconsideration of the doctrine of the mature minor. Journal of Medicine 
& Philosophy, 38(3), 249–255. doi:10.1093/jmp/jht015 
Pasternak, R. H., Geller, G., Parrish, C., & Cheng, T. L. (2006). Adolescent and parent 
perceptions on youth participation in risk behavior research. Archives of 
Pediatrics & Adolescent Medicine, 160(11), 1159–1166. 
doi:10.1001/archpedi.160.11.1159 
Pinquart, M., & Shen, Y. (2011). Depressive symptoms in children and adolescents with 
chronic physical illness: An updated meta-analysis. Journal of Pediatric 
Psychology, 36(4), 375–384. doi:10.1093/jpepsy/jsq104 
Rice, M., & Broome, M. E. (2004). Incentives for children in research. Journal of 
Nursing Scholarship, 36(2), 167–172. doi:10.1111/j.1547-5069.2004.04030.x 
Risjord, M., & Greenberg, J. (2002). When IRBs disagree: Waiving parental consent for 
sexual health research on adolescents. IRB: Ethics & Human Research, 24(2), 8–
14. doi:10.2307/3563651 
Rothman, A. A., & Wagner, E. H. (2003). Chronic illness management: What is the role 
of primary care? Annals of Internal Medicine, 138(3), 256–261. 
doi:10.7326/0003-4819-138-3-200302040-00034 
Santelli, J. S., Rosenfeld, W. D., DuRant, R. H., Dubler, N., Morreale, M., English, A., & 
Rogers, A. S. (1995). Guidelines for adolescent health research: A position paper 
of the Society for Adolescent Medicine. Journal of Adolescent Health, 17(5), 
270–276. doi:10.1016/1054-139X(95)00181-Q 
  
112 
Scherer, D. G., Brody, J. L., Annett, R. D., Turner, C., Dalen, J., & Yoon, Y. (2013). 
Empirically derived knowledge on adolescent assent to pediatric biomedical 
research. AJOB Primary Research, 4(3), 15–26. 
doi:10.1080/21507716.2013.806967 
Schmotzer, G. L. (2012). Barriers and facilitators to participation of minorities in clinical 
trials. Ethnicity & Disease, 22(2), 226–230.  
Sentell, T., Baker, K. K., Onaka, A., & Braun, K. (2011). Low health literacy and poor 
health status in Asian Americans and Pacific Islanders in Hawai’i. Journal of 
Health Communication, 16(Suppl 3), 279–294. 
doi:10.1080/10810730.2011.604390 
Shavers-Hornaday, V. L., Lynch, C. F., Burmeister, L. F., & Toner, J. C. (1997). Why are 
African Americans under-represented in medical research studies? Impediments 
to participation. Ethnicity & Health, 2(1/2), 31–45. 
doi:10.1080/13557858.1997.9961813  
Singer, E. (2003). Exploring the meaning of consent: Participation in research and beliefs 
about risks and benefits. Journal of Official Statistics, 19(3), 273–285.  
Singer, E., & Couper, M. P. (2008). Do incentives exert undue influence on survey 
participation? Experimental evidence. Journal of Empirical Research on Human 
Research Ethics, 3(3), 49–56. doi:10.1525/jer.2008.3.3.49 
Spigarelli, M. (2008). Adolescent participation in research. Journal of Adolescent Health, 
43(1), 1–2. doi:10.1016/j.jadohealth.2008.04.004 
  
113 
Spriggs, M., & Fry, C. (2015). Children, biological samples, and broad consent. The 
American Journal of Bioethics, 15(9), 70–72. 
doi:10.1080/15265161.2015.1062173 
Swanson, G. M., & Ward, A. J. (1995). Recruiting minorities into clinical trials: Toward 
a participant-friendly system. Journal of the National Cancer Institute, 87(23), 
1747–1759. doi:10.1093/jnci/87.23.1747 
Turrell, S. L., Peterson-Badali, M., & Katzman, D. K. (2011). Consent to treatment in 
adolescents with anorexia nervosa. International Journal of Eating Disorders, 
44(8), 703–707. doi:10.1002/eat.20870 
United Nations Economic and Social Council. (2012). Monitoring of population 
programmes, focusing on adolescents and youth. New York, NY: United Nations 
Economic and Social Council. 
US Department of Health & Human Services. (2009). Protection of human subjects. 45 
CFR § 46. 
Verheggen, F. W., Nieman, F., & Jonkers, R. (1998). Determinants of patient 
participation in clinical studies requiring informed consent: Why patients enter a 
clinical trial. Patient Education and Counseling, 35(2), 111–125. 
doi:10.1016/S0738-3991(98)00060-3 
Weithorn, L. A., & Campbell, S. B. (1982). The competency of children and adolescents 
to make informed treatment decisions. Child Development, 53(6), 1589–1598. 
doi:10.2307/1130087 
Wertheimer, A., & Miller, F. G. (2008). Payment for research participation: A coercive 
offer? Journal of Medical Ethics, 34(5), 389–392. doi:10.1136/jme.2007.021857 
  
114 
Wertheimer, A., & Miller, F. G. (2014). There are (STILL) no coercive offers. Journal of 
Medical Ethics, 40(9), 592–593. doi:10.1136/medethics-2013-101510 
World Medical Association. (1964). Declaration of Helsinki, ethical principles for 
medical research involving human subjects. 52nd WMA General Assembly, 
Edinburgh, Scotland.  
Yancey, A. K., Ortega, A. N., & Kumanyika, S. K. (2006). Effective recruitment and 
retention of minority research participants. Annual Review of Public Health, 
27(1), 1–28. doi:10.1146/annurev.publhealth.27.021405.102113 
  
Curriculum Vitae 
Kyle A. McGregor 
Education  
PhD in Social Work 
Minor concentration: advanced research methods 
Indiana University 
Completed: December 2015 
Achievements:  
-Social Work Fellow, Leadership Education in Adolescent Health (LEAH) Fellowship 
through Indiana University School of Medicine, Section of Adolescent Medicine 
(HRSA/MCHB) (2012-2013) 
-LEAH Fellowship Coordinator, Indiana University School of Medicine, Section of 
Adolescent Medicine (2013-2014) 
-Clinical Ethics Fellow, Charles Warren Fairbanks Center for Medical Ethics (2014-
2015) 
-TL1 Fellow, the National Institutes of Health, National Center for Advancing 
Translational Sciences & Clinical and Translational Sciences Award (2014-2016) 
-Visiting Scholar, Yale Interdisciplinary Center for Bioethics (2014, 2015) 
 
Master of Social Work 
Concentration: interpersonal practice with children and youth in families and society 
University of Michigan Ann Arbor 
Completed: April 2011 
Achievements:  
-Assistant Editor of The Michigan Journal of Social Work and Social Welfare 
 
Master of Public Policy 
Concentration: Social service and economic policy 
Loyola University Chicago  
Completed: December 2009 
Achievements:  
-Loyola Arts and Sciences Grant (2008-2009) 
 
Bachelor of Science in Political Science  
Grand Valley State University 
Completed: April 2008 
Achievements:  
-Senior thesis: Arts Funding as a First Amendment Issue: Solutions for a Broken System 
(2008) 
-Michigan Merit Scholarship (2004-2006) 
 
Teaching 
Global Health Ethics—Yale University, summer 2015 
Interdisciplinary Approaches to Clinical Ethics—Yale University, summer 2015 
School of Medicine—behavioral health rotation, IUSM Med-Peds, spring 2015 
Social Work Research—Indiana University, undergraduate, spring 2015 
  
Organizational Theory and Practice—Indiana University, undergraduate, fall 2014 
Social Work Research Methods I (online)—Indiana University, graduate, summer 2014 
Social Work Practicum I—Indiana University, graduate, spring 2014 
Human Behavior in the Social Environment I—Indiana University, graduate, fall 2013 
Organizational Theory and Practice—Indiana University, undergraduate, fall 2013 
Social Work Research Methods II—Indiana University, graduate, summer 2013 
 
Awards 
Excellence in Teaching Award—Indiana University, 2014 
Indy’s Best and Brightest (Health & Life Sciences), 2014 & 2015 
Inspire Award (for outstanding mentorship in education & nonprofit sector), 2015 
Top Student in the School of Social Work—Indiana University Graduate and 
Professional Student Government, 2015 
Indiana University Graduate School Elite 50 (award for top 50 students in the IU 
graduate school), 2015 
 
Selected Refereed Presentations 
McGregor, KA, Ott, MA. (2015). An assessment of adolescent capacity to consent to 
biobanking research. National Translational Science Meeting, Washington DC. 
Warus, JD, McGregor, KA, Ott, MA. (2015). Social and developmental influences on 
sexual risk behavior and STI rates in college-aged males. Journal of Adolescent 
Health, 56(2), S75. Society for Adolescent Health and Medicine Annual Meeting, 
Los Angeles, CA. 
McGregor, KA, Aalsma, MC, Ott, MA. (2015). Adolescent perceptions of importance, 
discomfort and interest with sexual behavior research. Oral presentation at the 
Society for Social Work and Research Annual Meeting, New Orleans, Louisiana. 
Harris, EM, McGregor, KA. (2015). A comparison of transgender and cisgender 
experiences in primary care. Oral presentation at the Society for Social Work and 
Research Annual Meeting, New Orleans, Louisiana. 
McGregor, KA, Hensel, DJ, Ott, MA. (2014). A structural equation model of IRB risk 
categorization and approvability in adolescent eating disorder research. Presented 
at Indiana University School of Medicine Research Symposium, Indianapolis, 
Indiana. 
McGregor, KA. (2014). Assessing adolescent capacity to participate in research. Oral 
presentation at the Association of Maternal Child Health Bureau Programs 
Annual Meeting, Washington DC.  
McGregor, KA, Hensel, DJ, Molnar EA, Ott, MA. (2014). Predictors of IRB risk 
categorization and approvability in adolescent sexual behavior research. Journal 
of Adolescent Health, 54(2), S22-23. Oral presentation at the Society for 
Adolescent Health and Medicine Annual Meeting, Austin, Texas. 
McGregor, KA, Hall, JA. (2014). Brief electronic screening of adolescents in primary 
health care. Journal of Adolescent Health, 54(2), S92-93. Oral presentation at the 
Society for Adolescent Health and Medicine Annual Meeting, Austin, Texas. 
McGregor, KA, Ott, MA, Zimet, GD, Adolescent Trials Network. (2014). Predictors of 
adolescent decision-making regarding HIV vaccine trial participation. Oral 
  
presentation at the Society for Social Work and Research Annual Meeting, San 
Antonio, Texas.  
McGregor, KA, Ott, MA, Zimet, GD. (2013). Gender differences in HIV vaccination 
clinical trial participation amongst at risk females and males who have sex with 
males. Presented at Indiana University School of Medicine Research Symposium, 
Indiana.  
McGregor, KA, Hall, JA. (2013). Why do adolescents and their parents participate in 
substance abuse treatment research? Journal of Adolescent Health, 52(2), S94. 
Presented at the Society of Adolescent Health and Medicine’s Annual 
Conference, Atlanta, Georgia. 
 
Invited Presentations 
McGregor, KA. (2015). Interprofessional ethics in action. Oral presentation at the 
NASW Northwest Indiana Social Work Conference, Merrillville, Indiana.  
McGregor, KA. (2015). From multidisciplinary to interdisciplinary: Ethics education as 
a conduit for enhanced communication. Oral presentation at the NASW Indiana 
Conference, South Bend, Indiana. 
McGregor, KA. (2014). Development of a capacity instrument for adolescent clinical 
trial participation. Oral presentation at the Charles Warren Fairbanks Center for 
Medical Ethics. 
McGregor, KA. (2014). Truly informed consent & research: Bridging a historical legacy 
of distrust. Oral presentation at Yale University Center for Bioethics, New Haven, 
Connecticut. 
McGregor, KA. (2014). Translational ethics: Putting bioethics education into 
translational research. Oral presentation at Yale University Center for Bioethics, 
New Haven, Connecticut. 
McGregor, KA. (2014). Interdisciplinary ethics education for social work students. Oral 
presentation at the Indiana University Social Work Symposium, Indianapolis, 
Indiana. 
McGregor, KA. (2014). Real world approaches to clinical ethics education. Oral 
presentation at the Northwest Indiana Social Work Conference, Merrillville, 
Indiana.  
 
Technical Reports 
Caring for Indiana Adolescents: Best Practices in Reproductive Health, Contraception, 
Confidentiality and LGBT Youth (2014). American Academy of Pediatrics, 
Section of Adolescent Health: Reproductive Training Grant. 
 
Articles in Preparation 
Pfeiffer, EJ, McGregor, KA, Ott, MA. Predictors of disclosure of sexually transmitted 
infections (STIs) to sexual partners among male college students. In press.  
McGregor, KA, Hensel, DJ, Ott, MA. IRB risk categorization and approvability in 
adolescent sexual behavior research.  
McGregor, KA, Hensel, DJ, Ott, MA, Zimet, GD, Adolescent Trials Network. Predictors 
of adolescent decision-making regarding HIV vaccine trial participation.  
  
Warus, JD, McGregor, KA, Ott, MA. Social and developmental influences on sexual 
risk behavior and STI rates in college-aged males.  
McGregor, KA, Hall, JA, Ott, MA. Development of a social work framework for 
research ethics.  
McGregor, KA, Hall, JA, Zimet, GD, Ott, MA. Development of a standardized measure 
of adolescent capacity to consent to biobanking research. 
McGregor, KA, Hall, JA, Wilkerson, DA, Bennett, LW, Zimet, GD, Ott, MA. A 
comparison of three capacity assessment tools adapted for use with adolescents 
wishing to participate in clinical research.  
McGregor, KA, Anderson, JJ, Ott, MA. Teaching social work practice ethics in an 
interprofessional environment. 
 
Grants Awarded 
Trainee/Dissertation Grant, Teens Having Capacity to Consent to Research-Chronic 
Illness (THiNCCR-CI). TL1-TR001107 & UL1 TR001108 (A. Shekhar, PI) from 
the National Institutes of Health, National Center for Advancing Translational 
Sciences & Clinical and Translational Sciences Award. 
Co-Investigator, Adolescent Electronic Preventative Screening in Primary Health Care 
Settings. (J. Hall, PI) Funding: $50,000. 2012-2014. 
Co-Investigator, Integrating Family therapy into Substance Abuse Treatment for Youth. 
(J. Hall, PI) Funding: $100,000 (Internal). 2012-2013. 
 
Professional Experience 
Indiana University School of Medicine Department of Adolescent Medicine, 
Indianapolis, IN—Social Work Fellow 
July 2012—Current 
-Clinical work in Adolescent Medicine clinics at Riley Hospital and Riley Specialty 
clinics.  
-Conducted advanced data analyses and generated reports for multiple research projects.  
-Participate in collecting data for projects centered on adolescent health. 
-Work collaboratively with physicians, nutritionists, psychologists, and nursing staff to 
provide comprehensive clinical and research services.  
 
Youth Contact, Hillsboro OR—Youth and Family Therapist 
May 2011—July 2012 
-Provide family and individual therapy to a diverse group of clientele (active caseload of 
25-30 families). 
-Maintain accurate and up-to-date case files on clients served. 
-Implement therapeutic interventions with a high degree of treatment model fidelity.  
-Work collaboratively with other staff members to help conceptualize and manage 
problems.  
 
University of Michigan School of Social Work, Ann Arbor MI —Research Assistant 
September 2010—May 2011 
  
-Worked on projects relating to mental health, substance abuse treatment, community 
organizing, and course design. 
-Worked on National Institute of Health Grant for community based implementation 
study.  
-Collaborated to provide comprehensive editing and technical writing support.  
-Developed educational resources for clinical social workers in Southeast Michigan.  
 
Holy Cross Children’s Services, Clinton MI—Residential Counselor  
September 2010—May 2011 
-Provide individual and group therapy to adolescent male sex offenders in a residential 
facility using TF-CBT and MST-PSB. 
-Conduct research on clinical practices and human services policies, and develop plans to 
implement best practices. 
-Worked on program development and training to increase program effectiveness.  
-Maintained accurate and up to date records and case notes.    
    
Service 
University Service 
Indiana University Health, Clinical Ethics Consultant, 2014-2015 
Indiana University Graduate & Professional Student Government, Student Representative 
2014-2015 
Indiana University PhD Curriculum Committee, Student Representative 2013-2015 
Michigan Journal of Social Work and Social Welfare, Assistant Editor 2010-2011 
 
 
